DE60024455T2 - Sulfonamidomethylphosphonat-BETA-LACTAMASE-Inhibitoren - Google Patents
Sulfonamidomethylphosphonat-BETA-LACTAMASE-Inhibitoren Download PDFInfo
- Publication number
- DE60024455T2 DE60024455T2 DE60024455T DE60024455T DE60024455T2 DE 60024455 T2 DE60024455 T2 DE 60024455T2 DE 60024455 T DE60024455 T DE 60024455T DE 60024455 T DE60024455 T DE 60024455T DE 60024455 T2 DE60024455 T2 DE 60024455T2
- Authority
- DE
- Germany
- Prior art keywords
- group
- aryl
- heteroaryl
- alkyl
- nmr
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 239000003781 beta lactamase inhibitor Substances 0.000 title abstract description 64
- 229940126813 beta-lactamase inhibitor Drugs 0.000 title abstract description 64
- 230000003115 biocidal effect Effects 0.000 claims abstract description 45
- 239000008194 pharmaceutical composition Substances 0.000 claims abstract description 16
- 150000001875 compounds Chemical class 0.000 claims description 148
- 125000000217 alkyl group Chemical group 0.000 claims description 72
- -1 5-dimethylamino-1-naphthyl group Chemical group 0.000 claims description 65
- 125000003118 aryl group Chemical group 0.000 claims description 65
- 125000001072 heteroaryl group Chemical group 0.000 claims description 60
- 102000006635 beta-lactamase Human genes 0.000 claims description 50
- 108090000204 Dipeptidase 1 Proteins 0.000 claims description 42
- 125000001153 fluoro group Chemical group F* 0.000 claims description 25
- 229910052739 hydrogen Inorganic materials 0.000 claims description 24
- 125000003710 aryl alkyl group Chemical group 0.000 claims description 23
- 125000004435 hydrogen atom Chemical class [H]* 0.000 claims description 23
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 20
- 125000000753 cycloalkyl group Chemical group 0.000 claims description 19
- 150000003839 salts Chemical class 0.000 claims description 18
- 239000003242 anti bacterial agent Substances 0.000 claims description 16
- 239000003782 beta lactam antibiotic agent Substances 0.000 claims description 16
- 239000002132 β-lactam antibiotic Substances 0.000 claims description 16
- 229940124586 β-lactam antibiotics Drugs 0.000 claims description 16
- 239000001257 hydrogen Substances 0.000 claims description 14
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 14
- 229910052799 carbon Inorganic materials 0.000 claims description 9
- 125000001309 chloro group Chemical group Cl* 0.000 claims description 9
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 claims description 9
- 125000001424 substituent group Chemical group 0.000 claims description 8
- 125000004434 sulfur atom Chemical group 0.000 claims description 8
- 125000005956 isoquinolyl group Chemical group 0.000 claims description 7
- 125000004430 oxygen atom Chemical group O* 0.000 claims description 7
- 125000005493 quinolyl group Chemical group 0.000 claims description 7
- 125000004076 pyridyl group Chemical group 0.000 claims description 6
- 125000004196 benzothienyl group Chemical group S1C(=CC2=C1C=CC=C2)* 0.000 claims description 5
- 125000001624 naphthyl group Chemical group 0.000 claims description 5
- 125000001544 thienyl group Chemical group 0.000 claims description 5
- 208000035143 Bacterial infection Diseases 0.000 claims description 4
- 208000022362 bacterial infectious disease Diseases 0.000 claims description 4
- 239000003937 drug carrier Substances 0.000 claims description 4
- 125000002541 furyl group Chemical group 0.000 claims description 4
- 238000002360 preparation method Methods 0.000 claims description 4
- 125000004987 dibenzofuryl group Chemical group C1(=CC=CC=2OC3=C(C21)C=CC=C3)* 0.000 claims description 3
- 125000006267 biphenyl group Chemical group 0.000 claims description 2
- 238000000034 method Methods 0.000 abstract description 74
- 230000001580 bacterial effect Effects 0.000 abstract description 37
- 239000000203 mixture Substances 0.000 abstract description 18
- 230000002401 inhibitory effect Effects 0.000 abstract description 15
- 150000003952 β-lactams Chemical class 0.000 abstract description 6
- 229930014626 natural product Natural products 0.000 abstract description 3
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 54
- 229940126085 β‑Lactamase Inhibitor Drugs 0.000 description 41
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 39
- BFXHJFKKRGVUMU-UHFFFAOYSA-N 4-fluorobenzenesulfonyl chloride Chemical compound FC1=CC=C(S(Cl)(=O)=O)C=C1 BFXHJFKKRGVUMU-UHFFFAOYSA-N 0.000 description 37
- RSOPTYAZDFSMTN-UHFFFAOYSA-N 2-chloropyridin-3-ol Chemical compound OC1=CC=CN=C1Cl RSOPTYAZDFSMTN-UHFFFAOYSA-N 0.000 description 36
- BTJIUGUIPKRLHP-UHFFFAOYSA-N 4-nitrophenol Chemical compound OC1=CC=C([N+]([O-])=O)C=C1 BTJIUGUIPKRLHP-UHFFFAOYSA-N 0.000 description 32
- 239000000243 solution Substances 0.000 description 30
- 239000007787 solid Substances 0.000 description 26
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 20
- ABLZXFCXXLZCGV-UHFFFAOYSA-N Phosphorous acid Chemical compound OP(O)=O ABLZXFCXXLZCGV-UHFFFAOYSA-N 0.000 description 19
- 238000012360 testing method Methods 0.000 description 19
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 18
- 239000003112 inhibitor Substances 0.000 description 18
- 238000011282 treatment Methods 0.000 description 18
- 125000000623 heterocyclic group Chemical group 0.000 description 17
- VLKZOEOYAKHREP-UHFFFAOYSA-N hexane Substances CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 15
- 238000003818 flash chromatography Methods 0.000 description 13
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 12
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 12
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 12
- 239000000908 ammonium hydroxide Substances 0.000 description 12
- 238000006243 chemical reaction Methods 0.000 description 12
- 230000000694 effects Effects 0.000 description 12
- 102000004190 Enzymes Human genes 0.000 description 11
- 108090000790 Enzymes Proteins 0.000 description 11
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 11
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 10
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 10
- 229910052757 nitrogen Inorganic materials 0.000 description 10
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 10
- 239000011541 reaction mixture Substances 0.000 description 10
- 230000002195 synergetic effect Effects 0.000 description 10
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 9
- 241000894006 Bacteria Species 0.000 description 9
- IYYIVELXUANFED-UHFFFAOYSA-N bromo(trimethyl)silane Chemical compound C[Si](C)(C)Br IYYIVELXUANFED-UHFFFAOYSA-N 0.000 description 9
- 239000000460 chlorine Substances 0.000 description 9
- 125000004433 nitrogen atom Chemical group N* 0.000 description 9
- 108020004256 Beta-lactamase Proteins 0.000 description 8
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 8
- 238000010828 elution Methods 0.000 description 8
- 241000588697 Enterobacter cloacae Species 0.000 description 7
- 102000030899 Serine-Type D-Ala-D-Ala Carboxypeptidase Human genes 0.000 description 7
- 108010004832 Serine-Type D-Ala-D-Ala Carboxypeptidase Proteins 0.000 description 7
- 235000019439 ethyl acetate Nutrition 0.000 description 7
- 238000000746 purification Methods 0.000 description 7
- FYSNRJHAOHDILO-UHFFFAOYSA-N thionyl chloride Chemical compound ClS(Cl)=O FYSNRJHAOHDILO-UHFFFAOYSA-N 0.000 description 7
- GRFNBEZIAWKNCO-UHFFFAOYSA-N 3-pyridinol Chemical compound OC1=CC=CN=C1 GRFNBEZIAWKNCO-UHFFFAOYSA-N 0.000 description 6
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 6
- 150000003863 ammonium salts Chemical class 0.000 description 6
- 125000004432 carbon atom Chemical group C* 0.000 description 6
- 238000004113 cell culture Methods 0.000 description 6
- 125000001559 cyclopropyl group Chemical group [H]C1([H])C([H])([H])C1([H])* 0.000 description 6
- 125000005843 halogen group Chemical group 0.000 description 6
- 239000000463 material Substances 0.000 description 6
- 239000002609 medium Substances 0.000 description 6
- DTUQWGWMVIHBKE-UHFFFAOYSA-N phenylacetaldehyde Chemical compound O=CCC1=CC=CC=C1 DTUQWGWMVIHBKE-UHFFFAOYSA-N 0.000 description 6
- VNNLHYZDXIBHKZ-UHFFFAOYSA-N thiophene-2-sulfonyl chloride Chemical compound ClS(=O)(=O)C1=CC=CS1 VNNLHYZDXIBHKZ-UHFFFAOYSA-N 0.000 description 6
- 241000606768 Haemophilus influenzae Species 0.000 description 5
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 5
- 241000191967 Staphylococcus aureus Species 0.000 description 5
- DRUIESSIVFYOMK-UHFFFAOYSA-N Trichloroacetonitrile Chemical compound ClC(Cl)(Cl)C#N DRUIESSIVFYOMK-UHFFFAOYSA-N 0.000 description 5
- 125000004448 alkyl carbonyl group Chemical group 0.000 description 5
- 229940088710 antibiotic agent Drugs 0.000 description 5
- 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 description 5
- 125000001511 cyclopentyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 5
- 238000011161 development Methods 0.000 description 5
- 150000005690 diesters Chemical class 0.000 description 5
- 239000000706 filtrate Substances 0.000 description 5
- 229910052736 halogen Inorganic materials 0.000 description 5
- 230000005764 inhibitory process Effects 0.000 description 5
- 125000000636 p-nitrophenyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1*)[N+]([O-])=O 0.000 description 5
- UEZVMMHDMIWARA-UHFFFAOYSA-M phosphonate Chemical compound [O-]P(=O)=O UEZVMMHDMIWARA-UHFFFAOYSA-M 0.000 description 5
- 239000002904 solvent Substances 0.000 description 5
- 238000003756 stirring Methods 0.000 description 5
- 229940124530 sulfonamide Drugs 0.000 description 5
- YBBRCQOCSYXUOC-UHFFFAOYSA-N sulfuryl dichloride Chemical compound ClS(Cl)(=O)=O YBBRCQOCSYXUOC-UHFFFAOYSA-N 0.000 description 5
- CYTQBVOFDCPGCX-UHFFFAOYSA-N trimethyl phosphite Chemical compound COP(OC)OC CYTQBVOFDCPGCX-UHFFFAOYSA-N 0.000 description 5
- 125000006552 (C3-C8) cycloalkyl group Chemical group 0.000 description 4
- WWKITRBMMRAWII-UHFFFAOYSA-N (thiophen-2-ylsulfonylamino)methylphosphonic acid Chemical compound OP(O)(=O)CNS(=O)(=O)C1=CC=CS1 WWKITRBMMRAWII-UHFFFAOYSA-N 0.000 description 4
- 0 *C(N(*)S(O)I)P(*)(*)=O Chemical compound *C(N(*)S(O)I)P(*)(*)=O 0.000 description 4
- KTFDYVNEGTXQCV-UHFFFAOYSA-N 2-Thiophenesulfonamide Chemical compound NS(=O)(=O)C1=CC=CS1 KTFDYVNEGTXQCV-UHFFFAOYSA-N 0.000 description 4
- WGYBIEOLAFYDEC-UHFFFAOYSA-N 5-bromothiophene-2-sulfonyl chloride Chemical compound ClS(=O)(=O)C1=CC=C(Br)S1 WGYBIEOLAFYDEC-UHFFFAOYSA-N 0.000 description 4
- 239000007993 MOPS buffer Substances 0.000 description 4
- 241001465754 Metazoa Species 0.000 description 4
- 229930040373 Paraformaldehyde Natural products 0.000 description 4
- 125000004453 alkoxycarbonyl group Chemical group 0.000 description 4
- 125000002877 alkyl aryl group Chemical group 0.000 description 4
- 125000004390 alkyl sulfonyl group Chemical group 0.000 description 4
- 125000004202 aminomethyl group Chemical group [H]N([H])C([H])([H])* 0.000 description 4
- 239000004599 antimicrobial Substances 0.000 description 4
- MVPPADPHJFYWMZ-UHFFFAOYSA-N chlorobenzene Chemical compound ClC1=CC=CC=C1 MVPPADPHJFYWMZ-UHFFFAOYSA-N 0.000 description 4
- 239000012043 crude product Substances 0.000 description 4
- LXCYSACZTOKNNS-UHFFFAOYSA-N diethoxy(oxo)phosphanium Chemical compound CCO[P+](=O)OCC LXCYSACZTOKNNS-UHFFFAOYSA-N 0.000 description 4
- 238000010790 dilution Methods 0.000 description 4
- 239000012895 dilution Substances 0.000 description 4
- 239000003814 drug Substances 0.000 description 4
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 4
- 238000001914 filtration Methods 0.000 description 4
- 125000001188 haloalkyl group Chemical group 0.000 description 4
- 150000002367 halogens Chemical class 0.000 description 4
- 230000001965 increasing effect Effects 0.000 description 4
- 239000012074 organic phase Substances 0.000 description 4
- 229910052760 oxygen Inorganic materials 0.000 description 4
- 229920002866 paraformaldehyde Polymers 0.000 description 4
- 125000003170 phenylsulfonyl group Chemical group C1(=CC=CC=C1)S(=O)(=O)* 0.000 description 4
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 4
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 4
- 125000006413 ring segment Chemical group 0.000 description 4
- 239000000741 silica gel Substances 0.000 description 4
- 229910002027 silica gel Inorganic materials 0.000 description 4
- 235000011121 sodium hydroxide Nutrition 0.000 description 4
- 150000003456 sulfonamides Chemical class 0.000 description 4
- 125000005147 toluenesulfonyl group Chemical group C=1(C(=CC=CC1)S(=O)(=O)*)C 0.000 description 4
- LHNIIDJCEODSHA-OQRUQETBSA-N (6r,7r)-3-[(e)-2-(2,4-dinitrophenyl)ethenyl]-8-oxo-7-[(2-thiophen-2-ylacetyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid Chemical compound N([C@H]1[C@H]2SCC(=C(N2C1=O)C(=O)O)\C=C\C=1C(=CC(=CC=1)[N+]([O-])=O)[N+]([O-])=O)C(=O)CC1=CC=CS1 LHNIIDJCEODSHA-OQRUQETBSA-N 0.000 description 3
- UZMQSZBTFGHLAH-UHFFFAOYSA-N 1-benzothiophene-2-sulfonamide Chemical compound C1=CC=C2SC(S(=O)(=O)N)=CC2=C1 UZMQSZBTFGHLAH-UHFFFAOYSA-N 0.000 description 3
- UUSLLECLCKTJQF-UHFFFAOYSA-N 2-(bromomethyl)isoindole-1,3-dione Chemical compound C1=CC=C2C(=O)N(CBr)C(=O)C2=C1 UUSLLECLCKTJQF-UHFFFAOYSA-N 0.000 description 3
- 125000000094 2-phenylethyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])C([H])([H])* 0.000 description 3
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 3
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 3
- WVDDGKGOMKODPV-UHFFFAOYSA-N Benzyl alcohol Chemical compound OCC1=CC=CC=C1 WVDDGKGOMKODPV-UHFFFAOYSA-N 0.000 description 3
- 229930186147 Cephalosporin Natural products 0.000 description 3
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 3
- SJRJJKPEHAURKC-UHFFFAOYSA-N N-Methylmorpholine Chemical compound CN1CCOCC1 SJRJJKPEHAURKC-UHFFFAOYSA-N 0.000 description 3
- 229930182555 Penicillin Natural products 0.000 description 3
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 3
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 3
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 3
- JTOIXAIKHQXCOL-UHFFFAOYSA-N [(4-fluorophenyl)sulfonylamino]methylphosphonic acid Chemical compound OP(O)(=O)CNS(=O)(=O)C1=CC=C(F)C=C1 JTOIXAIKHQXCOL-UHFFFAOYSA-N 0.000 description 3
- 125000004442 acylamino group Chemical group 0.000 description 3
- 239000002168 alkylating agent Substances 0.000 description 3
- 229940100198 alkylating agent Drugs 0.000 description 3
- 125000003368 amide group Chemical group 0.000 description 3
- 230000000845 anti-microbial effect Effects 0.000 description 3
- KGOJOGFECFDNOF-UHFFFAOYSA-N azane;[1-benzothiophen-2-ylsulfonyl(methyl)amino]methyl-(4-nitrophenoxy)phosphinic acid Chemical compound N.C=1C2=CC=CC=C2SC=1S(=O)(=O)N(C)CP(O)(=O)OC1=CC=C([N+]([O-])=O)C=C1 KGOJOGFECFDNOF-UHFFFAOYSA-N 0.000 description 3
- 239000012267 brine Substances 0.000 description 3
- 229910052794 bromium Inorganic materials 0.000 description 3
- 229940124587 cephalosporin Drugs 0.000 description 3
- 150000001780 cephalosporins Chemical class 0.000 description 3
- 238000002512 chemotherapy Methods 0.000 description 3
- 229910052801 chlorine Inorganic materials 0.000 description 3
- 239000003085 diluting agent Substances 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- BJXYHBKEQFQVES-NWDGAFQWSA-N enpatoran Chemical compound N[C@H]1CN(C[C@H](C1)C(F)(F)F)C1=C2C=CC=NC2=C(C=C1)C#N BJXYHBKEQFQVES-NWDGAFQWSA-N 0.000 description 3
- 239000000284 extract Substances 0.000 description 3
- 238000004108 freeze drying Methods 0.000 description 3
- XNTWONAICPPJDM-UHFFFAOYSA-N furan-3-sulfonamide Chemical compound NS(=O)(=O)C=1C=COC=1 XNTWONAICPPJDM-UHFFFAOYSA-N 0.000 description 3
- 238000000338 in vitro Methods 0.000 description 3
- 238000011081 inoculation Methods 0.000 description 3
- 230000000670 limiting effect Effects 0.000 description 3
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 3
- 235000019341 magnesium sulphate Nutrition 0.000 description 3
- 230000002906 microbiologic effect Effects 0.000 description 3
- PYLWMHQQBFSUBP-UHFFFAOYSA-N monofluorobenzene Chemical compound FC1=CC=CC=C1 PYLWMHQQBFSUBP-UHFFFAOYSA-N 0.000 description 3
- 125000004923 naphthylmethyl group Chemical group C1(=CC=CC2=CC=CC=C12)C* 0.000 description 3
- 239000012299 nitrogen atmosphere Substances 0.000 description 3
- 150000002960 penicillins Chemical class 0.000 description 3
- 229940100595 phenylacetaldehyde Drugs 0.000 description 3
- XKJCHHZQLQNZHY-UHFFFAOYSA-N phthalimide Chemical compound C1=CC=C2C(=O)NC(=O)C2=C1 XKJCHHZQLQNZHY-UHFFFAOYSA-N 0.000 description 3
- 229920000137 polyphosphoric acid Polymers 0.000 description 3
- 229940002612 prodrug Drugs 0.000 description 3
- 239000000651 prodrug Substances 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 3
- JQJOGAGLBDBMLU-UHFFFAOYSA-N pyridine-2-sulfonyl chloride Chemical compound ClS(=O)(=O)C1=CC=CC=N1 JQJOGAGLBDBMLU-UHFFFAOYSA-N 0.000 description 3
- 230000002829 reductive effect Effects 0.000 description 3
- 229920006395 saturated elastomer Polymers 0.000 description 3
- HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical compound O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 description 3
- 239000011550 stock solution Substances 0.000 description 3
- 125000005420 sulfonamido group Chemical group S(=O)(=O)(N*)* 0.000 description 3
- 125000004178 (C1-C4) alkyl group Chemical group 0.000 description 2
- 125000004454 (C1-C6) alkoxycarbonyl group Chemical group 0.000 description 2
- 125000004890 (C1-C6) alkylamino group Chemical group 0.000 description 2
- 125000004916 (C1-C6) alkylcarbonyl group Chemical group 0.000 description 2
- LBUJPTNKIBCYBY-UHFFFAOYSA-N 1,2,3,4-tetrahydroquinoline Chemical compound C1=CC=C2CCCNC2=C1 LBUJPTNKIBCYBY-UHFFFAOYSA-N 0.000 description 2
- HBEDSQVIWPRPAY-UHFFFAOYSA-N 2,3-dihydrobenzofuran Chemical compound C1=CC=C2OCCC2=C1 HBEDSQVIWPRPAY-UHFFFAOYSA-N 0.000 description 2
- OQZWKEPQLJBODT-UHFFFAOYSA-N 2,5-dichloro-1-[2,5-dichloro-3-(2,2-diethoxyethyl)phenyl]sulfanyl-3-(2,2-diethoxyethyl)benzene Chemical compound CCOC(OCC)CC1=CC(Cl)=CC(SC=2C(=C(CC(OCC)OCC)C=C(Cl)C=2)Cl)=C1Cl OQZWKEPQLJBODT-UHFFFAOYSA-N 0.000 description 2
- QIULLHZMZMGGFH-UHFFFAOYSA-N 2,5-dichlorobenzenethiol Chemical compound SC1=CC(Cl)=CC=C1Cl QIULLHZMZMGGFH-UHFFFAOYSA-N 0.000 description 2
- WDBHXTMUHJGHAN-UHFFFAOYSA-N 2-(dimethoxyphosphorylmethyl)isoindole-1,3-dione Chemical compound C1=CC=C2C(=O)N(CP(=O)(OC)OC)C(=O)C2=C1 WDBHXTMUHJGHAN-UHFFFAOYSA-N 0.000 description 2
- 238000013030 3-step procedure Methods 0.000 description 2
- ALBQXDHCMLLQMB-UHFFFAOYSA-N 4-phenylbenzenesulfonyl chloride Chemical compound C1=CC(S(=O)(=O)Cl)=CC=C1C1=CC=CC=C1 ALBQXDHCMLLQMB-UHFFFAOYSA-N 0.000 description 2
- YYROPELSRYBVMQ-UHFFFAOYSA-N 4-toluenesulfonyl chloride Chemical compound CC1=CC=C(S(Cl)(=O)=O)C=C1 YYROPELSRYBVMQ-UHFFFAOYSA-N 0.000 description 2
- ORPHLVJBJOCHBR-UHFFFAOYSA-N 403-19-0 Chemical compound OC1=CC=C([N+]([O-])=O)C=C1F ORPHLVJBJOCHBR-UHFFFAOYSA-N 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 2
- HZZVJAQRINQKSD-UHFFFAOYSA-N Clavulanic acid Natural products OC(=O)C1C(=CCO)OC2CC(=O)N21 HZZVJAQRINQKSD-UHFFFAOYSA-N 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- 241000588724 Escherichia coli Species 0.000 description 2
- OAKJQQAXSVQMHS-UHFFFAOYSA-N Hydrazine Chemical compound NN OAKJQQAXSVQMHS-UHFFFAOYSA-N 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 2
- AMIMRNSIRUDHCM-UHFFFAOYSA-N Isopropylaldehyde Chemical compound CC(C)C=O AMIMRNSIRUDHCM-UHFFFAOYSA-N 0.000 description 2
- RJQXTJLFIWVMTO-TYNCELHUSA-N Methicillin Chemical compound COC1=CC=CC(OC)=C1C(=O)N[C@@H]1C(=O)N2[C@@H](C(O)=O)C(C)(C)S[C@@H]21 RJQXTJLFIWVMTO-TYNCELHUSA-N 0.000 description 2
- MZRVEZGGRBJDDB-UHFFFAOYSA-N N-Butyllithium Chemical compound [Li]CCCC MZRVEZGGRBJDDB-UHFFFAOYSA-N 0.000 description 2
- JRNVZBWKYDBUCA-UHFFFAOYSA-N N-chlorosuccinimide Chemical compound ClN1C(=O)CCC1=O JRNVZBWKYDBUCA-UHFFFAOYSA-N 0.000 description 2
- OFBQJSOFQDEBGM-UHFFFAOYSA-N Pentane Chemical compound CCCCC OFBQJSOFQDEBGM-UHFFFAOYSA-N 0.000 description 2
- 108090000279 Peptidyltransferases Proteins 0.000 description 2
- 241000589516 Pseudomonas Species 0.000 description 2
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 2
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 2
- WQDUMFSSJAZKTM-UHFFFAOYSA-N Sodium methoxide Chemical compound [Na+].[O-]C WQDUMFSSJAZKTM-UHFFFAOYSA-N 0.000 description 2
- RAHZWNYVWXNFOC-UHFFFAOYSA-N Sulphur dioxide Chemical compound O=S=O RAHZWNYVWXNFOC-UHFFFAOYSA-N 0.000 description 2
- AGARJXOSLYRTFA-UHFFFAOYSA-N [1-benzothiophen-2-ylsulfonyl(methyl)amino]methylphosphonic acid Chemical compound C1=CC=C2SC(S(=O)(=O)N(CP(O)(O)=O)C)=CC2=C1 AGARJXOSLYRTFA-UHFFFAOYSA-N 0.000 description 2
- JRXPSWRAZBRQJF-UHFFFAOYSA-N [2-phenyl-1-(thiophen-2-ylsulfonylamino)ethyl]phosphonic acid Chemical compound C=1C=CSC=1S(=O)(=O)NC(P(O)(=O)O)CC1=CC=CC=C1 JRXPSWRAZBRQJF-UHFFFAOYSA-N 0.000 description 2
- 125000000738 acetamido group Chemical group [H]C([H])([H])C(=O)N([H])[*] 0.000 description 2
- WETWJCDKMRHUPV-UHFFFAOYSA-N acetyl chloride Chemical compound CC(Cl)=O WETWJCDKMRHUPV-UHFFFAOYSA-N 0.000 description 2
- 239000012346 acetyl chloride Substances 0.000 description 2
- 125000002252 acyl group Chemical group 0.000 description 2
- 125000004423 acyloxy group Chemical group 0.000 description 2
- 125000003545 alkoxy group Chemical group 0.000 description 2
- 125000005115 alkyl carbamoyl group Chemical group 0.000 description 2
- 125000005422 alkyl sulfonamido group Chemical group 0.000 description 2
- 125000003277 amino group Chemical group 0.000 description 2
- 239000008346 aqueous phase Substances 0.000 description 2
- 125000005116 aryl carbamoyl group Chemical group 0.000 description 2
- 125000004104 aryloxy group Chemical group 0.000 description 2
- 125000004429 atom Chemical group 0.000 description 2
- UZFGCSMYCORPMP-UHFFFAOYSA-N azane;(1-benzothiophen-2-ylsulfonylamino)methyl-(4-nitrophenoxy)phosphinic acid Chemical compound N.C=1C2=CC=CC=C2SC=1S(=O)(=O)NCP(=O)(O)OC1=CC=C([N+]([O-])=O)C=C1 UZFGCSMYCORPMP-UHFFFAOYSA-N 0.000 description 2
- GNYNAKUHFQILCG-UHFFFAOYSA-N azane;(3-chlorophenoxy)-[(thiophen-2-ylsulfonylamino)methyl]phosphinic acid Chemical compound N.C=1C=CC(Cl)=CC=1OP(=O)(O)CNS(=O)(=O)C1=CC=CS1 GNYNAKUHFQILCG-UHFFFAOYSA-N 0.000 description 2
- NGHZZWAEFPQWQP-UHFFFAOYSA-N azane;[methyl(thiophen-2-ylsulfonyl)amino]methyl-(4-nitrophenoxy)phosphinic acid Chemical compound N.C=1C=CSC=1S(=O)(=O)N(C)CP(O)(=O)OC1=CC=C([N+]([O-])=O)C=C1 NGHZZWAEFPQWQP-UHFFFAOYSA-N 0.000 description 2
- HUMNYLRZRPPJDN-UHFFFAOYSA-N benzaldehyde Chemical compound O=CC1=CC=CC=C1 HUMNYLRZRPPJDN-UHFFFAOYSA-N 0.000 description 2
- 125000000043 benzamido group Chemical group [H]N([*])C(=O)C1=C([H])C([H])=C([H])C([H])=C1[H] 0.000 description 2
- 125000004618 benzofuryl group Chemical group O1C(=CC2=C1C=CC=C2)* 0.000 description 2
- 125000000051 benzyloxy group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])O* 0.000 description 2
- 125000003460 beta-lactamyl group Chemical group 0.000 description 2
- 230000036983 biotransformation Effects 0.000 description 2
- 239000006161 blood agar Substances 0.000 description 2
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Chemical compound BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 2
- 125000001246 bromo group Chemical group Br* 0.000 description 2
- 239000000872 buffer Substances 0.000 description 2
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 2
- FJDQFPXHSGXQBY-UHFFFAOYSA-L caesium carbonate Chemical compound [Cs+].[Cs+].[O-]C([O-])=O FJDQFPXHSGXQBY-UHFFFAOYSA-L 0.000 description 2
- 229910000024 caesium carbonate Inorganic materials 0.000 description 2
- 125000003917 carbamoyl group Chemical group [H]N([H])C(*)=O 0.000 description 2
- 125000001951 carbamoylamino group Chemical group C(N)(=O)N* 0.000 description 2
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 210000002421 cell wall Anatomy 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 239000012320 chlorinating reagent Substances 0.000 description 2
- 239000007330 chocolate agar Substances 0.000 description 2
- HZZVJAQRINQKSD-PBFISZAISA-N clavulanic acid Chemical compound OC(=O)[C@H]1C(=C/CO)/O[C@@H]2CC(=O)N21 HZZVJAQRINQKSD-PBFISZAISA-N 0.000 description 2
- 229960003324 clavulanic acid Drugs 0.000 description 2
- 238000003776 cleavage reaction Methods 0.000 description 2
- 125000004093 cyano group Chemical group *C#N 0.000 description 2
- 125000004122 cyclic group Chemical group 0.000 description 2
- 238000010511 deprotection reaction Methods 0.000 description 2
- 239000003480 eluent Substances 0.000 description 2
- OAYLNYINCPYISS-UHFFFAOYSA-N ethyl acetate;hexane Chemical class CCCCCC.CCOC(C)=O OAYLNYINCPYISS-UHFFFAOYSA-N 0.000 description 2
- 229910052731 fluorine Inorganic materials 0.000 description 2
- 239000001963 growth medium Substances 0.000 description 2
- 239000012456 homogeneous solution Substances 0.000 description 2
- 230000007062 hydrolysis Effects 0.000 description 2
- 238000006460 hydrolysis reaction Methods 0.000 description 2
- 230000003301 hydrolyzing effect Effects 0.000 description 2
- 125000004029 hydroxymethyl group Chemical group [H]OC([H])([H])* 0.000 description 2
- 230000002779 inactivation Effects 0.000 description 2
- 230000000854 inhibitional effect Effects 0.000 description 2
- 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 description 2
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 2
- WHIDHHUCCTYJKA-UHFFFAOYSA-N isoquinoline-5-sulfonyl chloride Chemical compound N1=CC=C2C(S(=O)(=O)Cl)=CC=CC2=C1 WHIDHHUCCTYJKA-UHFFFAOYSA-N 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 125000004170 methylsulfonyl group Chemical group [H]C([H])([H])S(*)(=O)=O 0.000 description 2
- 229960003085 meticillin Drugs 0.000 description 2
- 244000005700 microbiome Species 0.000 description 2
- LYPFQUUNIQRQFM-UHFFFAOYSA-N n-(dimethoxyphosphorylmethyl)-n-methylthiophene-2-sulfonamide Chemical class COP(=O)(OC)CN(C)S(=O)(=O)C1=CC=CS1 LYPFQUUNIQRQFM-UHFFFAOYSA-N 0.000 description 2
- 231100000252 nontoxic Toxicity 0.000 description 2
- 230000003000 nontoxic effect Effects 0.000 description 2
- 125000004043 oxo group Chemical group O=* 0.000 description 2
- 239000012071 phase Substances 0.000 description 2
- 125000000951 phenoxy group Chemical group [H]C1=C([H])C([H])=C(O*)C([H])=C1[H] 0.000 description 2
- 229960002292 piperacillin Drugs 0.000 description 2
- WCMIIGXFCMNQDS-IDYPWDAWSA-M piperacillin sodium Chemical compound [Na+].O=C1C(=O)N(CC)CCN1C(=O)N[C@H](C=1C=CC=CC=1)C(=O)N[C@@H]1C(=O)N2[C@@H](C([O-])=O)C(C)(C)S[C@@H]21 WCMIIGXFCMNQDS-IDYPWDAWSA-M 0.000 description 2
- 239000013612 plasmid Substances 0.000 description 2
- 239000013641 positive control Substances 0.000 description 2
- 229910000027 potassium carbonate Inorganic materials 0.000 description 2
- 235000011181 potassium carbonates Nutrition 0.000 description 2
- 235000011118 potassium hydroxide Nutrition 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- CDRNYKLYADJTMN-UHFFFAOYSA-N pyridine-3-sulfonyl chloride Chemical compound ClS(=O)(=O)C1=CC=CN=C1 CDRNYKLYADJTMN-UHFFFAOYSA-N 0.000 description 2
- 230000007017 scission Effects 0.000 description 2
- FTHBPRVVDKYQDX-UHFFFAOYSA-M sodium (furan-3-ylsulfonylamino)methyl-(4-nitrophenoxy)phosphinate Chemical compound [Na+].[O-][N+](=O)c1ccc(OP([O-])(=O)CNS(=O)(=O)c2ccoc2)cc1 FTHBPRVVDKYQDX-UHFFFAOYSA-M 0.000 description 2
- VTUQHEGUXYKLIU-UHFFFAOYSA-M sodium;(2-chloropyridin-3-yl)oxy-[[(4-fluorophenyl)sulfonylamino]methyl]phosphinate Chemical compound [Na+].C=1C=CN=C(Cl)C=1OP(=O)([O-])CNS(=O)(=O)C1=CC=C(F)C=C1 VTUQHEGUXYKLIU-UHFFFAOYSA-M 0.000 description 2
- 238000003860 storage Methods 0.000 description 2
- 150000003455 sulfinic acids Chemical class 0.000 description 2
- 229910052717 sulfur Inorganic materials 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- LPQZKKCYTLCDGQ-WEDXCCLWSA-N tazobactam Chemical compound C([C@]1(C)S([C@H]2N(C(C2)=O)[C@H]1C(O)=O)(=O)=O)N1C=CN=N1 LPQZKKCYTLCDGQ-WEDXCCLWSA-N 0.000 description 2
- 229960003865 tazobactam Drugs 0.000 description 2
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 2
- FPGGTKZVZWFYPV-UHFFFAOYSA-M tetrabutylammonium fluoride Chemical compound [F-].CCCC[N+](CCCC)(CCCC)CCCC FPGGTKZVZWFYPV-UHFFFAOYSA-M 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 125000000335 thiazolyl group Chemical group 0.000 description 2
- OHKOGUYZJXTSFX-KZFFXBSXSA-N ticarcillin Chemical compound C=1([C@@H](C(O)=O)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)C=CSC=1 OHKOGUYZJXTSFX-KZFFXBSXSA-N 0.000 description 2
- 229960004659 ticarcillin Drugs 0.000 description 2
- 230000000699 topical effect Effects 0.000 description 2
- 238000001665 trituration Methods 0.000 description 2
- 108010087967 type I signal peptidase Proteins 0.000 description 2
- 239000008096 xylene Substances 0.000 description 2
- MGRVRXRGTBOSHW-UHFFFAOYSA-N (aminomethyl)phosphonic acid Chemical compound NCP(O)(O)=O MGRVRXRGTBOSHW-UHFFFAOYSA-N 0.000 description 1
- AVYBHNDWIHYCDM-UHFFFAOYSA-N (dimethylamino)methylphosphonic acid Chemical compound CN(C)CP(O)(O)=O AVYBHNDWIHYCDM-UHFFFAOYSA-N 0.000 description 1
- XINSWKFBCHUMBT-UHFFFAOYSA-N (furan-3-ylsulfonylamino)methylphosphonic acid Chemical compound OP(O)(=O)CNS(=O)(=O)C=1C=COC=1 XINSWKFBCHUMBT-UHFFFAOYSA-N 0.000 description 1
- XIMGXQDIPMBKRH-UHFFFAOYSA-N (pyridin-2-ylsulfonylamino)methylphosphonic acid Chemical compound OP(O)(=O)CNS(=O)(=O)C1=CC=CC=N1 XIMGXQDIPMBKRH-UHFFFAOYSA-N 0.000 description 1
- FJPKPLYRVXSFKZ-UHFFFAOYSA-N (thiophen-3-ylsulfonylamino)methylphosphonic acid Chemical compound OP(O)(=O)CNS(=O)(=O)C=1C=CSC=1 FJPKPLYRVXSFKZ-UHFFFAOYSA-N 0.000 description 1
- DHKHKXVYLBGOIT-UHFFFAOYSA-N 1,1-Diethoxyethane Chemical compound CCOC(C)OCC DHKHKXVYLBGOIT-UHFFFAOYSA-N 0.000 description 1
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 1
- PHTUJLCKNUFTTE-UHFFFAOYSA-N 1-dichlorophosphoryl-4-nitrobenzene Chemical compound [O-][N+](=O)C1=CC=C(P(Cl)(Cl)=O)C=C1 PHTUJLCKNUFTTE-UHFFFAOYSA-N 0.000 description 1
- QQFWMPUXPLBWTG-UHFFFAOYSA-N 2,4,6-trifluorophenol Chemical compound OC1=C(F)C=C(F)C=C1F QQFWMPUXPLBWTG-UHFFFAOYSA-N 0.000 description 1
- PVJZBZSCGJAWNG-UHFFFAOYSA-N 2,4,6-trimethylbenzenesulfonyl chloride Chemical compound CC1=CC(C)=C(S(Cl)(=O)=O)C(C)=C1 PVJZBZSCGJAWNG-UHFFFAOYSA-N 0.000 description 1
- SSFSNKZUKDBPIT-UHFFFAOYSA-N 2,4-dinitrobenzenesulfonyl chloride Chemical compound [O-][N+](=O)C1=CC=C(S(Cl)(=O)=O)C([N+]([O-])=O)=C1 SSFSNKZUKDBPIT-UHFFFAOYSA-N 0.000 description 1
- BXCOSWRSIISQSL-UHFFFAOYSA-N 2,5-dichlorobenzenesulfonyl chloride Chemical compound ClC1=CC=C(Cl)C(S(Cl)(=O)=O)=C1 BXCOSWRSIISQSL-UHFFFAOYSA-N 0.000 description 1
- PAYROHWFGZADBR-UHFFFAOYSA-N 2-[[4-amino-5-(5-iodo-4-methoxy-2-propan-2-ylphenoxy)pyrimidin-2-yl]amino]propane-1,3-diol Chemical compound C1=C(I)C(OC)=CC(C(C)C)=C1OC1=CN=C(NC(CO)CO)N=C1N PAYROHWFGZADBR-UHFFFAOYSA-N 0.000 description 1
- VFPWGZNNRSQPBT-UHFFFAOYSA-N 2-bromobenzenesulfonyl chloride Chemical compound ClS(=O)(=O)C1=CC=CC=C1Br VFPWGZNNRSQPBT-UHFFFAOYSA-N 0.000 description 1
- YKHQFTANTNMYPP-UHFFFAOYSA-N 2-bromopyridin-3-ol Chemical group OC1=CC=CN=C1Br YKHQFTANTNMYPP-UHFFFAOYSA-N 0.000 description 1
- WPHUUIODWRNJLO-UHFFFAOYSA-N 2-nitrobenzenesulfonyl chloride Chemical compound [O-][N+](=O)C1=CC=CC=C1S(Cl)(=O)=O WPHUUIODWRNJLO-UHFFFAOYSA-N 0.000 description 1
- WMPPDTMATNBGJN-UHFFFAOYSA-N 2-phenylethylbromide Chemical compound BrCCC1=CC=CC=C1 WMPPDTMATNBGJN-UHFFFAOYSA-N 0.000 description 1
- 125000003903 2-propenyl group Chemical group [H]C([*])([H])C([H])=C([H])[H] 0.000 description 1
- NYIBPWGZGSXURD-UHFFFAOYSA-N 3,4-dichlorobenzenesulfonyl chloride Chemical compound ClC1=CC=C(S(Cl)(=O)=O)C=C1Cl NYIBPWGZGSXURD-UHFFFAOYSA-N 0.000 description 1
- MESJRHHDBDCQTH-UHFFFAOYSA-N 3-(dimethylamino)phenol Chemical compound CN(C)C1=CC=CC(O)=C1 MESJRHHDBDCQTH-UHFFFAOYSA-N 0.000 description 1
- HORNXRXVQWOLPJ-UHFFFAOYSA-N 3-chlorophenol Chemical compound OC1=CC=CC(Cl)=C1 HORNXRXVQWOLPJ-UHFFFAOYSA-N 0.000 description 1
- WGFNCAIKIYRGTE-UHFFFAOYSA-N 4-(bromomethyl)isoindole-1,3-dione Chemical compound BrCC1=CC=CC2=C1C(=O)NC2=O WGFNCAIKIYRGTE-UHFFFAOYSA-N 0.000 description 1
- SEWNAJIUKSTYOP-UHFFFAOYSA-N 4-chloro-3-nitrobenzenesulfonyl chloride Chemical compound [O-][N+](=O)C1=CC(S(Cl)(=O)=O)=CC=C1Cl SEWNAJIUKSTYOP-UHFFFAOYSA-N 0.000 description 1
- ZLYBFBAHAQEEQQ-UHFFFAOYSA-N 4-chlorobenzenesulfonyl chloride Chemical compound ClC1=CC=C(S(Cl)(=O)=O)C=C1 ZLYBFBAHAQEEQQ-UHFFFAOYSA-N 0.000 description 1
- WXNZTHHGJRFXKQ-UHFFFAOYSA-N 4-chlorophenol Chemical compound OC1=CC=C(Cl)C=C1 WXNZTHHGJRFXKQ-UHFFFAOYSA-N 0.000 description 1
- DTJVECUKADWGMO-UHFFFAOYSA-N 4-methoxybenzenesulfonyl chloride Chemical compound COC1=CC=C(S(Cl)(=O)=O)C=C1 DTJVECUKADWGMO-UHFFFAOYSA-N 0.000 description 1
- UQRONKZLYKUEMO-UHFFFAOYSA-N 4-methyl-1-(2,4,6-trimethylphenyl)pent-4-en-2-one Chemical group CC(=C)CC(=O)Cc1c(C)cc(C)cc1C UQRONKZLYKUEMO-UHFFFAOYSA-N 0.000 description 1
- JXRGUPLJCCDGKG-UHFFFAOYSA-N 4-nitrobenzenesulfonyl chloride Chemical compound [O-][N+](=O)C1=CC=C(S(Cl)(=O)=O)C=C1 JXRGUPLJCCDGKG-UHFFFAOYSA-N 0.000 description 1
- YEZADZMMVHWFIY-UHFFFAOYSA-N 4-tert-butylbenzenesulfonyl chloride Chemical compound CC(C)(C)C1=CC=C(S(Cl)(=O)=O)C=C1 YEZADZMMVHWFIY-UHFFFAOYSA-N 0.000 description 1
- TUIDQYRZDZRHPQ-UHFFFAOYSA-N 5-chloropyridin-3-ol Chemical compound OC1=CN=CC(Cl)=C1 TUIDQYRZDZRHPQ-UHFFFAOYSA-N 0.000 description 1
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical group [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 1
- 239000005725 8-Hydroxyquinoline Substances 0.000 description 1
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 1
- 125000000041 C6-C10 aryl group Chemical group 0.000 description 1
- 125000005915 C6-C14 aryl group Chemical group 0.000 description 1
- YXWWHNCQZBVZPV-UHFFFAOYSA-N CC(c1c(C)cccc1)=O Chemical compound CC(c1c(C)cccc1)=O YXWWHNCQZBVZPV-UHFFFAOYSA-N 0.000 description 1
- FQTBFWOUORRFPL-ARJAWSKDSA-N CC/C=C\C(O)=C(N)N Chemical compound CC/C=C\C(O)=C(N)N FQTBFWOUORRFPL-ARJAWSKDSA-N 0.000 description 1
- LCEWRJZMWNEILY-UHFFFAOYSA-N CCOC(CSc(cc(cc1)Cl)c1Cl)OCC Chemical compound CCOC(CSc(cc(cc1)Cl)c1Cl)OCC LCEWRJZMWNEILY-UHFFFAOYSA-N 0.000 description 1
- QCMYYKRYFNMIEC-UHFFFAOYSA-N COP(O)=O Chemical class COP(O)=O QCMYYKRYFNMIEC-UHFFFAOYSA-N 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical group [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- GNWUOVJNSFPWDD-XMZRARIVSA-M Cefoxitin sodium Chemical compound [Na+].N([C@]1(OC)C(N2C(=C(COC(N)=O)CS[C@@H]21)C([O-])=O)=O)C(=O)CC1=CC=CS1 GNWUOVJNSFPWDD-XMZRARIVSA-M 0.000 description 1
- KZBUYRJDOAKODT-UHFFFAOYSA-N Chlorine Chemical compound ClCl KZBUYRJDOAKODT-UHFFFAOYSA-N 0.000 description 1
- NJLHHACGWKAWKL-UHFFFAOYSA-N ClP(Cl)=O Chemical compound ClP(Cl)=O NJLHHACGWKAWKL-UHFFFAOYSA-N 0.000 description 1
- VRYQNDLMXNCHLI-UHFFFAOYSA-N Clc(cc1)c(CCS2)c2c1Cl Chemical compound Clc(cc1)c(CCS2)c2c1Cl VRYQNDLMXNCHLI-UHFFFAOYSA-N 0.000 description 1
- 206010059866 Drug resistance Diseases 0.000 description 1
- 241000194032 Enterococcus faecalis Species 0.000 description 1
- 239000004593 Epoxy Substances 0.000 description 1
- 101000740462 Escherichia coli Beta-lactamase TEM Proteins 0.000 description 1
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 description 1
- 241000606790 Haemophilus Species 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 241000588749 Klebsiella oxytoca Species 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- PZHZFVPFVHGFPE-UHFFFAOYSA-N NS(c1cc(c(Cl)ccc2Cl)c2[s]1)(=O)=O Chemical compound NS(c1cc(c(Cl)ccc2Cl)c2[s]1)(=O)=O PZHZFVPFVHGFPE-UHFFFAOYSA-N 0.000 description 1
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 1
- 241001307210 Pene Species 0.000 description 1
- 108700020474 Penicillin-Binding Proteins Proteins 0.000 description 1
- 241000932075 Priacanthus hamrur Species 0.000 description 1
- UIIMBOGNXHQVGW-DEQYMQKBSA-M Sodium bicarbonate-14C Chemical compound [Na+].O[14C]([O-])=O UIIMBOGNXHQVGW-DEQYMQKBSA-M 0.000 description 1
- 241000122971 Stenotrophomonas Species 0.000 description 1
- 241000122973 Stenotrophomonas maltophilia Species 0.000 description 1
- 241000187433 Streptomyces clavuligerus Species 0.000 description 1
- 241001430333 Streptomyces sp. R61 Species 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- 239000004098 Tetracycline Substances 0.000 description 1
- 108010059993 Vancomycin Proteins 0.000 description 1
- AGGLWUCHIKKURA-UHFFFAOYSA-N [(5-bromothiophen-2-yl)sulfonylamino]methylphosphonic acid Chemical compound OP(O)(=O)CNS(=O)(=O)C1=CC=C(Br)S1 AGGLWUCHIKKURA-UHFFFAOYSA-N 0.000 description 1
- CXZGNJSIKIEPJA-UHFFFAOYSA-M [Na+].Cc1ccc(cc1)S(=O)(=O)NCP([O-])(=O)Oc1ccc(cc1)[N+]([O-])=O Chemical compound [Na+].Cc1ccc(cc1)S(=O)(=O)NCP([O-])(=O)Oc1ccc(cc1)[N+]([O-])=O CXZGNJSIKIEPJA-UHFFFAOYSA-M 0.000 description 1
- JMGDPMOEXQOGIT-UHFFFAOYSA-M [Na+].[N+](=O)([O-])C1=CC=C(C=C1)OP([O-])(=O)CNS(=O)(=O)C1=C(C=C(C=C1C)C)C Chemical compound [Na+].[N+](=O)([O-])C1=CC=C(C=C1)OP([O-])(=O)CNS(=O)(=O)C1=C(C=C(C=C1C)C)C JMGDPMOEXQOGIT-UHFFFAOYSA-M 0.000 description 1
- RDYIFYOTLWDYFR-UHFFFAOYSA-M [Na+].[N+](=O)([O-])C1=CC=C(C=C1)OP([O-])(=O)CNS(=O)(=O)C1=C(C=CC(=C1)Cl)Cl Chemical compound [Na+].[N+](=O)([O-])C1=CC=C(C=C1)OP([O-])(=O)CNS(=O)(=O)C1=C(C=CC(=C1)Cl)Cl RDYIFYOTLWDYFR-UHFFFAOYSA-M 0.000 description 1
- DNHMDGUMKFUMOO-UHFFFAOYSA-M [Na+].[N+](=O)([O-])C1=CC=C(C=C1)OP([O-])=O Chemical compound [Na+].[N+](=O)([O-])C1=CC=C(C=C1)OP([O-])=O DNHMDGUMKFUMOO-UHFFFAOYSA-M 0.000 description 1
- KBPSILJSFKKOES-UHFFFAOYSA-M [Na+].[O-]P(=O)(CNS(=O)(=O)c1cccc(NC(=O)Nc2ccccc2)c1)Oc1cccnc1Cl Chemical compound [Na+].[O-]P(=O)(CNS(=O)(=O)c1cccc(NC(=O)Nc2ccccc2)c1)Oc1cccnc1Cl KBPSILJSFKKOES-UHFFFAOYSA-M 0.000 description 1
- XLQWNRMPPKTNLT-UHFFFAOYSA-M [Na+].[O-][N+](=O)c1ccc(OP([O-])(=O)CNS(=O)(=O)c2ccc3c(c2)oc2ccccc32)cc1 Chemical compound [Na+].[O-][N+](=O)c1ccc(OP([O-])(=O)CNS(=O)(=O)c2ccc3c(c2)oc2ccccc32)cc1 XLQWNRMPPKTNLT-UHFFFAOYSA-M 0.000 description 1
- FZRVNJIPROORCQ-UHFFFAOYSA-M [Na+].[O-][N+](=O)c1ccc(OP([O-])(=O)CNS(=O)(=O)c2cccc3ccccc23)cc1 Chemical compound [Na+].[O-][N+](=O)c1ccc(OP([O-])(=O)CNS(=O)(=O)c2cccc3ccccc23)cc1 FZRVNJIPROORCQ-UHFFFAOYSA-M 0.000 description 1
- MFPYMZCIEHZWGP-UHFFFAOYSA-M [Na+].[O-][N+](=O)c1ccc(OP([O-])(=O)CNS(=O)(=O)c2cccc3cccnc23)cc1 Chemical compound [Na+].[O-][N+](=O)c1ccc(OP([O-])(=O)CNS(=O)(=O)c2cccc3cccnc23)cc1 MFPYMZCIEHZWGP-UHFFFAOYSA-M 0.000 description 1
- JLUXCPITFZYLJL-UHFFFAOYSA-M [Na+].[O-][N+](=O)c1ccc(OP([O-])(=O)CNS(=O)(=O)c2ccoc2)c(F)c1 Chemical compound [Na+].[O-][N+](=O)c1ccc(OP([O-])(=O)CNS(=O)(=O)c2ccoc2)c(F)c1 JLUXCPITFZYLJL-UHFFFAOYSA-M 0.000 description 1
- BATAKLONSKCOSG-UHFFFAOYSA-N [methyl(thiophen-2-ylsulfonyl)amino]methylphosphonic acid Chemical compound OP(=O)(O)CN(C)S(=O)(=O)C1=CC=CS1 BATAKLONSKCOSG-UHFFFAOYSA-N 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- 125000000218 acetic acid group Chemical group C(C)(=O)* 0.000 description 1
- 125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 238000013019 agitation Methods 0.000 description 1
- 230000001476 alcoholic effect Effects 0.000 description 1
- 150000001299 aldehydes Chemical class 0.000 description 1
- 125000001931 aliphatic group Chemical group 0.000 description 1
- 125000003342 alkenyl group Chemical group 0.000 description 1
- 125000003282 alkyl amino group Chemical group 0.000 description 1
- 150000001350 alkyl halides Chemical class 0.000 description 1
- 125000000304 alkynyl group Chemical group 0.000 description 1
- HSFWRNGVRCDJHI-UHFFFAOYSA-N alpha-acetylene Natural products C#C HSFWRNGVRCDJHI-UHFFFAOYSA-N 0.000 description 1
- 150000001408 amides Chemical class 0.000 description 1
- 125000004103 aminoalkyl group Chemical group 0.000 description 1
- 229940126575 aminoglycoside Drugs 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- 235000011114 ammonium hydroxide Nutrition 0.000 description 1
- 125000002178 anthracenyl group Chemical group C1(=CC=CC2=CC3=CC=CC=C3C=C12)* 0.000 description 1
- 230000002924 anti-infective effect Effects 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 125000001769 aryl amino group Chemical group 0.000 description 1
- 125000005129 aryl carbonyl group Chemical group 0.000 description 1
- 125000004391 aryl sulfonyl group Chemical group 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- DHMMIUJMFWSWGD-UHFFFAOYSA-N azane;(2-chloropyridin-3-yl)oxy-[2-methyl-1-(thiophen-2-ylsulfonylamino)propyl]phosphinic acid Chemical compound N.C=1C=CN=C(Cl)C=1OP(O)(=O)C(C(C)C)NS(=O)(=O)C1=CC=CS1 DHMMIUJMFWSWGD-UHFFFAOYSA-N 0.000 description 1
- YFSIBGQDSNSAAG-UHFFFAOYSA-N azane;(4-chlorophenoxy)-[(thiophen-2-ylsulfonylamino)methyl]phosphinic acid Chemical compound N.C=1C=C(Cl)C=CC=1OP(=O)(O)CNS(=O)(=O)C1=CC=CS1 YFSIBGQDSNSAAG-UHFFFAOYSA-N 0.000 description 1
- AZBGTLZECMASNF-UHFFFAOYSA-N azane;(4-nitrophenoxy)-[2-phenyl-1-(thiophen-2-ylsulfonylamino)ethyl]phosphinic acid Chemical compound N.C=1C=CC=CC=1CC(NS(=O)(=O)C=1SC=CC=1)P(=O)(O)OC1=CC=C([N+]([O-])=O)C=C1 AZBGTLZECMASNF-UHFFFAOYSA-N 0.000 description 1
- HHHVKEYUQUYHAD-UHFFFAOYSA-N azane;[2-(1-benzothiophen-2-ylsulfonyl)ethylamino]methyl-(4-nitrophenoxy)phosphinic acid Chemical compound N.C=1C2=CC=CC=C2SC=1S(=O)(=O)CCNCP(=O)(O)OC1=CC=C([N+]([O-])=O)C=C1 HHHVKEYUQUYHAD-UHFFFAOYSA-N 0.000 description 1
- DCDMWNAVBWFJAG-UHFFFAOYSA-N azane;[2-methyl-1-(thiophen-2-ylsulfonylamino)propyl]-(4-nitrophenoxy)phosphinic acid Chemical compound N.C=1C=C([N+]([O-])=O)C=CC=1OP(O)(=O)C(C(C)C)NS(=O)(=O)C1=CC=CS1 DCDMWNAVBWFJAG-UHFFFAOYSA-N 0.000 description 1
- POVYIRCCRJDEKV-UHFFFAOYSA-N azane;[[2-(1-benzothiophen-2-ylsulfonyl)-2-phenylethyl]amino]methyl-(4-nitrophenoxy)phosphinic acid Chemical compound N.C=1C=C([N+]([O-])=O)C=CC=1OP(=O)(O)CNCC(S(=O)(=O)C=1SC2=CC=CC=C2C=1)C1=CC=CC=C1 POVYIRCCRJDEKV-UHFFFAOYSA-N 0.000 description 1
- HBNOQOWOAKTSRN-UHFFFAOYSA-N azane;[[2-(1-benzothiophen-2-ylsulfonyl)phenyl]methylamino]methyl-(4-nitrophenoxy)phosphinic acid Chemical compound N.C=1C=CC=C(S(=O)(=O)C=2SC3=CC=CC=C3C=2)C=1CNCP(=O)(O)OC1=CC=C([N+]([O-])=O)C=C1 HBNOQOWOAKTSRN-UHFFFAOYSA-N 0.000 description 1
- 125000004069 aziridinyl group Chemical group 0.000 description 1
- 230000003385 bacteriostatic effect Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- IKWQWOFXRCUIFT-UHFFFAOYSA-N benzene-1,2-dicarbohydrazide Chemical compound NNC(=O)C1=CC=CC=C1C(=O)NN IKWQWOFXRCUIFT-UHFFFAOYSA-N 0.000 description 1
- VJRITMATACIYAF-UHFFFAOYSA-N benzenesulfonohydrazide Chemical compound NNS(=O)(=O)C1=CC=CC=C1 VJRITMATACIYAF-UHFFFAOYSA-N 0.000 description 1
- CSKNSYBAZOQPLR-UHFFFAOYSA-N benzenesulfonyl chloride Chemical compound ClS(=O)(=O)C1=CC=CC=C1 CSKNSYBAZOQPLR-UHFFFAOYSA-N 0.000 description 1
- 235000019445 benzyl alcohol Nutrition 0.000 description 1
- AGEZXYOZHKGVCM-UHFFFAOYSA-N benzyl bromide Chemical compound BrCC1=CC=CC=C1 AGEZXYOZHKGVCM-UHFFFAOYSA-N 0.000 description 1
- 108010084251 beta-lactamase L1 Proteins 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000036765 blood level Effects 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 229940041011 carbapenems Drugs 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 230000003197 catalytic effect Effects 0.000 description 1
- 229960002682 cefoxitin Drugs 0.000 description 1
- 229940000162 ceftriaxone 250 mg Drugs 0.000 description 1
- 230000030833 cell death Effects 0.000 description 1
- WIIZWVCIJKGZOK-RKDXNWHRSA-N chloramphenicol Chemical compound ClC(Cl)C(=O)N[C@H](CO)[C@H](O)C1=CC=C([N+]([O-])=O)C=C1 WIIZWVCIJKGZOK-RKDXNWHRSA-N 0.000 description 1
- 229960005091 chloramphenicol Drugs 0.000 description 1
- WORJEOGGNQDSOE-UHFFFAOYSA-N chloroform;methanol Chemical compound OC.ClC(Cl)Cl WORJEOGGNQDSOE-UHFFFAOYSA-N 0.000 description 1
- 125000006378 chloropyridyl group Chemical group 0.000 description 1
- 238000011260 co-administration Methods 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 238000012790 confirmation Methods 0.000 description 1
- 238000004132 cross linking Methods 0.000 description 1
- 238000002425 crystallisation Methods 0.000 description 1
- 230000008025 crystallization Effects 0.000 description 1
- 125000001995 cyclobutyl group Chemical group [H]C1([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 1
- 125000000582 cycloheptyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 description 1
- 125000000596 cyclohexenyl group Chemical group C1(=CCCCC1)* 0.000 description 1
- 125000000640 cyclooctyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C([H])([H])C1([H])[H] 0.000 description 1
- 125000002433 cyclopentenyl group Chemical group C1(=CCCC1)* 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- CGJNXSWIIBSXII-UHFFFAOYSA-N dibenzofuran-3-sulfonyl chloride Chemical compound C1=CC=C2C3=CC=C(S(=O)(=O)Cl)C=C3OC2=C1 CGJNXSWIIBSXII-UHFFFAOYSA-N 0.000 description 1
- VILAVOFMIJHSJA-UHFFFAOYSA-N dicarbon monoxide Chemical group [C]=C=O VILAVOFMIJHSJA-UHFFFAOYSA-N 0.000 description 1
- SPWVRYZQLGQKGK-UHFFFAOYSA-N dichloromethane;hexane Chemical class ClCCl.CCCCCC SPWVRYZQLGQKGK-UHFFFAOYSA-N 0.000 description 1
- 125000004177 diethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 125000001664 diethylamino group Chemical group [H]C([H])([H])C([H])([H])N(*)C([H])([H])C([H])([H])[H] 0.000 description 1
- 125000002147 dimethylamino group Chemical group [H]C([H])([H])N(*)C([H])([H])[H] 0.000 description 1
- 231100000673 dose–response relationship Toxicity 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 229940032049 enterococcus faecalis Drugs 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 125000002534 ethynyl group Chemical group [H]C#C* 0.000 description 1
- 239000000945 filler Substances 0.000 description 1
- 125000003983 fluorenyl group Chemical group C1(=CC=CC=2C3=CC=CC=C3CC12)* 0.000 description 1
- 239000011737 fluorine Substances 0.000 description 1
- PCBBEIXTVWWTAK-UHFFFAOYSA-N furan-3-sulfonyl chloride Chemical compound ClS(=O)(=O)C=1C=COC=1 PCBBEIXTVWWTAK-UHFFFAOYSA-N 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 229940047650 haemophilus influenzae Drugs 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 125000005842 heteroatom Chemical group 0.000 description 1
- KDCIHNCMPUBDKT-UHFFFAOYSA-N hexane;propan-2-one Chemical class CC(C)=O.CCCCCC KDCIHNCMPUBDKT-UHFFFAOYSA-N 0.000 description 1
- 125000004051 hexyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- 125000002768 hydroxyalkyl group Chemical group 0.000 description 1
- 125000002883 imidazolyl group Chemical group 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 238000011065 in-situ storage Methods 0.000 description 1
- 230000000415 inactivating effect Effects 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 125000001041 indolyl group Chemical group 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 239000002054 inoculum Substances 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 229910052740 iodine Inorganic materials 0.000 description 1
- HVTICUPFWKNHNG-UHFFFAOYSA-N iodoethane Chemical compound CCI HVTICUPFWKNHNG-UHFFFAOYSA-N 0.000 description 1
- INQOMBQAUSQDDS-UHFFFAOYSA-N iodomethane Chemical compound IC INQOMBQAUSQDDS-UHFFFAOYSA-N 0.000 description 1
- 230000002427 irreversible effect Effects 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 229960003350 isoniazid Drugs 0.000 description 1
- QRXWMOHMRWLFEY-UHFFFAOYSA-N isoniazide Chemical compound NNC(=O)C1=CC=NC=C1 QRXWMOHMRWLFEY-UHFFFAOYSA-N 0.000 description 1
- 125000000842 isoxazolyl group Chemical group 0.000 description 1
- 239000003446 ligand Substances 0.000 description 1
- 239000003120 macrolide antibiotic agent Substances 0.000 description 1
- 229940041033 macrolides Drugs 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 230000001404 mediated effect Effects 0.000 description 1
- 239000002207 metabolite Substances 0.000 description 1
- OJURWUUOVGOHJZ-UHFFFAOYSA-N methyl 2-[(2-acetyloxyphenyl)methyl-[2-[(2-acetyloxyphenyl)methyl-(2-methoxy-2-oxoethyl)amino]ethyl]amino]acetate Chemical compound C=1C=CC=C(OC(C)=O)C=1CN(CC(=O)OC)CCN(CC(=O)OC)CC1=CC=CC=C1OC(C)=O OJURWUUOVGOHJZ-UHFFFAOYSA-N 0.000 description 1
- VAOCPAMSLUNLGC-UHFFFAOYSA-N metronidazole Chemical compound CC1=NC=C([N+]([O-])=O)N1CCO VAOCPAMSLUNLGC-UHFFFAOYSA-N 0.000 description 1
- 229960000282 metronidazole Drugs 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 150000004682 monohydrates Chemical class 0.000 description 1
- HDZGCSFEDULWCS-UHFFFAOYSA-N monomethylhydrazine Chemical compound CNN HDZGCSFEDULWCS-UHFFFAOYSA-N 0.000 description 1
- 125000004573 morpholin-4-yl group Chemical group N1(CCOCC1)* 0.000 description 1
- JOSZFSPXCQYEKJ-UHFFFAOYSA-N n-(dimethoxyphosphorylmethyl)-4-fluorobenzenesulfonamide Chemical compound COP(=O)(OC)CNS(=O)(=O)C1=CC=C(F)C=C1 JOSZFSPXCQYEKJ-UHFFFAOYSA-N 0.000 description 1
- LZFSJRQLINBWLL-UHFFFAOYSA-N n-(dimethoxyphosphorylmethyl)-n-methyl-1-benzothiophene-2-sulfonamide Chemical compound C1=CC=C2SC(S(=O)(=O)N(C)CP(=O)(OC)OC)=CC2=C1 LZFSJRQLINBWLL-UHFFFAOYSA-N 0.000 description 1
- BLODGYCWFCDDDW-UHFFFAOYSA-N n-(dimethoxyphosphorylmethyl)thiophene-2-sulfonamide Chemical compound COP(=O)(OC)CNS(=O)(=O)C1=CC=CS1 BLODGYCWFCDDDW-UHFFFAOYSA-N 0.000 description 1
- KFRUZWFKPHIRPK-UHFFFAOYSA-N n-(phenylcarbamoyl)sulfamoyl chloride Chemical compound ClS(=O)(=O)NC(=O)NC1=CC=CC=C1 KFRUZWFKPHIRPK-UHFFFAOYSA-N 0.000 description 1
- YNHIODWGFMOMCD-UHFFFAOYSA-N n-[bis(3-chlorophenoxy)phosphorylmethyl]thiophene-2-sulfonamide Chemical compound ClC1=CC=CC(OP(=O)(CNS(=O)(=O)C=2SC=CC=2)OC=2C=C(Cl)C=CC=2)=C1 YNHIODWGFMOMCD-UHFFFAOYSA-N 0.000 description 1
- DASJFYAPNPUBGG-UHFFFAOYSA-N naphthalene-1-sulfonyl chloride Chemical compound C1=CC=C2C(S(=O)(=O)Cl)=CC=CC2=C1 DASJFYAPNPUBGG-UHFFFAOYSA-N 0.000 description 1
- OPECTNGATDYLSS-UHFFFAOYSA-N naphthalene-2-sulfonyl chloride Chemical compound C1=CC=CC2=CC(S(=O)(=O)Cl)=CC=C21 OPECTNGATDYLSS-UHFFFAOYSA-N 0.000 description 1
- 239000013642 negative control Substances 0.000 description 1
- 239000002547 new drug Substances 0.000 description 1
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 description 1
- 125000006501 nitrophenyl group Chemical group 0.000 description 1
- 230000000269 nucleophilic effect Effects 0.000 description 1
- 239000012044 organic layer Substances 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 125000000160 oxazolidinyl group Chemical group 0.000 description 1
- 125000002971 oxazolyl group Chemical group 0.000 description 1
- 229960003540 oxyquinoline Drugs 0.000 description 1
- QNGNSVIICDLXHT-UHFFFAOYSA-N para-ethylbenzaldehyde Natural products CCC1=CC=C(C=O)C=C1 QNGNSVIICDLXHT-UHFFFAOYSA-N 0.000 description 1
- 150000002961 penems Chemical class 0.000 description 1
- 125000000538 pentafluorophenyl group Chemical group FC1=C(F)C(F)=C(*)C(F)=C1F 0.000 description 1
- 125000001147 pentyl group Chemical group C(CCCC)* 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 238000001050 pharmacotherapy Methods 0.000 description 1
- 150000002989 phenols Chemical class 0.000 description 1
- OAHKWDDSKCRNFE-UHFFFAOYSA-N phenylmethanesulfonyl chloride Chemical compound ClS(=O)(=O)CC1=CC=CC=C1 OAHKWDDSKCRNFE-UHFFFAOYSA-N 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 125000004193 piperazinyl group Chemical group 0.000 description 1
- 125000003386 piperidinyl group Chemical group 0.000 description 1
- 239000011736 potassium bicarbonate Substances 0.000 description 1
- 235000015497 potassium bicarbonate Nutrition 0.000 description 1
- 229910000028 potassium bicarbonate Inorganic materials 0.000 description 1
- TYJJADVDDVDEDZ-UHFFFAOYSA-M potassium hydrogencarbonate Chemical compound [K+].OC([O-])=O TYJJADVDDVDEDZ-UHFFFAOYSA-M 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 238000002953 preparative HPLC Methods 0.000 description 1
- 125000006308 propyl amino group Chemical group 0.000 description 1
- 125000002568 propynyl group Chemical group [*]C#CC([H])([H])[H] 0.000 description 1
- 150000003217 pyrazoles Chemical class 0.000 description 1
- 125000003226 pyrazolyl group Chemical group 0.000 description 1
- 125000000714 pyrimidinyl group Chemical group 0.000 description 1
- 125000000719 pyrrolidinyl group Chemical group 0.000 description 1
- 125000000168 pyrrolyl group Chemical group 0.000 description 1
- MCJGNVYPOGVAJF-UHFFFAOYSA-N quinolin-8-ol Chemical group C1=CN=C2C(O)=CC=CC2=C1 MCJGNVYPOGVAJF-UHFFFAOYSA-N 0.000 description 1
- JUYUYCIJACTHMK-UHFFFAOYSA-N quinoline-8-sulfonyl chloride Chemical compound C1=CN=C2C(S(=O)(=O)Cl)=CC=CC2=C1 JUYUYCIJACTHMK-UHFFFAOYSA-N 0.000 description 1
- 150000007660 quinolones Chemical class 0.000 description 1
- 125000001567 quinoxalinyl group Chemical group N1=C(C=NC2=CC=CC=C12)* 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 230000008261 resistance mechanism Effects 0.000 description 1
- 230000002441 reversible effect Effects 0.000 description 1
- 238000012552 review Methods 0.000 description 1
- JQXXHWHPUNPDRT-WLSIYKJHSA-N rifampicin Chemical compound O([C@](C1=O)(C)O/C=C/[C@@H]([C@H]([C@@H](OC(C)=O)[C@H](C)[C@H](O)[C@H](C)[C@@H](O)[C@@H](C)\C=C\C=C(C)/C(=O)NC=2C(O)=C3C([O-])=C4C)C)OC)C4=C1C3=C(O)C=2\C=N\N1CC[NH+](C)CC1 JQXXHWHPUNPDRT-WLSIYKJHSA-N 0.000 description 1
- 229960001225 rifampicin Drugs 0.000 description 1
- 239000000523 sample Substances 0.000 description 1
- 238000013207 serial dilution Methods 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- DIUIDFGHVYSEFY-UHFFFAOYSA-M sodium (2-chloropyridin-3-yl)oxy-[(furan-3-ylsulfonylamino)methyl]phosphinate Chemical compound [Na+].[O-]P(=O)(CNS(=O)(=O)c1ccoc1)Oc1cccnc1Cl DIUIDFGHVYSEFY-UHFFFAOYSA-M 0.000 description 1
- RPHYYGNFTQXIJO-UHFFFAOYSA-M sodium (2-chloropyridin-3-yl)oxy-[(isoquinolin-5-ylsulfonylamino)methyl]phosphinate Chemical compound [Na+].[O-]P(=O)(CNS(=O)(=O)c1cccc2cnccc12)Oc1cccnc1Cl RPHYYGNFTQXIJO-UHFFFAOYSA-M 0.000 description 1
- KUTOEXNESFAJAJ-UHFFFAOYSA-M sodium (2-chloropyridin-3-yl)oxy-[(pyridin-2-ylsulfonylamino)methyl]phosphinate Chemical compound [Na+].ClC1=NC=CC=C1OP([O-])(=O)CNS(=O)(=O)C1=NC=CC=C1 KUTOEXNESFAJAJ-UHFFFAOYSA-M 0.000 description 1
- QIPRXTUGZBOFPE-UHFFFAOYSA-M sodium (2-chloropyridin-3-yl)oxy-[(thiophen-3-ylsulfonylamino)methyl]phosphinate Chemical compound [Na+].[O-]P(=O)(CNS(=O)(=O)c1ccsc1)Oc1cccnc1Cl QIPRXTUGZBOFPE-UHFFFAOYSA-M 0.000 description 1
- BNAJTBYKCDNRSL-UHFFFAOYSA-M sodium (2-chloropyridin-3-yl)oxy-[[(4-phenylphenyl)sulfonylamino]methyl]phosphinate Chemical compound [Na+].ClC1=NC=CC=C1OP([O-])(=O)CNS(=O)(=O)C1=CC=C(C=C1)C1=CC=CC=C1 BNAJTBYKCDNRSL-UHFFFAOYSA-M 0.000 description 1
- VHBZTQOSFLDWQU-UHFFFAOYSA-M sodium (2-fluoro-4-nitrophenoxy)-[(thiophen-3-ylsulfonylamino)methyl]phosphinate Chemical compound [Na+].[O-][N+](=O)c1ccc(OP([O-])(=O)CNS(=O)(=O)c2ccsc2)c(F)c1 VHBZTQOSFLDWQU-UHFFFAOYSA-M 0.000 description 1
- VPCYPLDEXOIOMT-UHFFFAOYSA-M sodium (4-nitrophenoxy)-[(pyridin-2-ylsulfonylamino)methyl]phosphinate Chemical compound [Na+].[N+](=O)([O-])C1=CC=C(C=C1)OP([O-])(=O)CNS(=O)(=O)C1=NC=CC=C1 VPCYPLDEXOIOMT-UHFFFAOYSA-M 0.000 description 1
- IMZHLZMTAYFYRT-UHFFFAOYSA-M sodium (4-nitrophenoxy)-[(pyridin-3-ylsulfonylamino)methyl]phosphinate Chemical compound [Na+].[O-][N+](=O)c1ccc(OP([O-])(=O)CNS(=O)(=O)c2cccnc2)cc1 IMZHLZMTAYFYRT-UHFFFAOYSA-M 0.000 description 1
- PNFZDKUSABFAPF-UHFFFAOYSA-M sodium (4-nitrophenoxy)-[(thiophen-2-ylsulfonylamino)methyl]phosphinate Chemical compound [Na+].[O-][N+](=O)c1ccc(OP([O-])(=O)CNS(=O)(=O)c2cccs2)cc1 PNFZDKUSABFAPF-UHFFFAOYSA-M 0.000 description 1
- QVSYOAOQHSLENJ-UHFFFAOYSA-M sodium (4-nitrophenoxy)-[(thiophen-3-ylsulfonylamino)methyl]phosphinate Chemical compound [Na+].[O-][N+](=O)c1ccc(OP([O-])(=O)CNS(=O)(=O)c2ccsc2)cc1 QVSYOAOQHSLENJ-UHFFFAOYSA-M 0.000 description 1
- OIPMKIUVXHLBKD-UHFFFAOYSA-M sodium (4-nitrophenoxy)-[[(2-nitrophenyl)sulfonylamino]methyl]phosphinate Chemical compound [Na+].[O-][N+](=O)c1ccc(OP([O-])(=O)CNS(=O)(=O)c2ccccc2[N+]([O-])=O)cc1 OIPMKIUVXHLBKD-UHFFFAOYSA-M 0.000 description 1
- PUPGONYOSLMDDS-UHFFFAOYSA-M sodium (4-nitrophenoxy)-[[(4-nitrophenyl)sulfonylamino]methyl]phosphinate Chemical compound [Na+].[O-][N+](=O)c1ccc(OP([O-])(=O)CNS(=O)(=O)c2ccc(cc2)[N+]([O-])=O)cc1 PUPGONYOSLMDDS-UHFFFAOYSA-M 0.000 description 1
- MAECDGGUAYLMEO-UHFFFAOYSA-M sodium (4-nitrophenoxy)-[[(4-phenylphenyl)sulfonylamino]methyl]phosphinate Chemical compound [Na+].[O-][N+](=O)c1ccc(OP([O-])(=O)CNS(=O)(=O)c2ccc(cc2)-c2ccccc2)cc1 MAECDGGUAYLMEO-UHFFFAOYSA-M 0.000 description 1
- ZBOGMIOHJYWASA-UHFFFAOYSA-M sodium (4-nitrophenoxy)-[[[4-(trifluoromethyl)phenyl]sulfonylamino]methyl]phosphinate Chemical compound [Na+].[O-][N+](=O)c1ccc(OP([O-])(=O)CNS(=O)(=O)c2ccc(cc2)C(F)(F)F)cc1 ZBOGMIOHJYWASA-UHFFFAOYSA-M 0.000 description 1
- AOUQQCVNASPOLA-UHFFFAOYSA-M sodium (benzylsulfonylamino)methyl-(4-nitrophenoxy)phosphinate Chemical compound [Na+].[N+](=O)([O-])C1=CC=C(C=C1)OP([O-])(=O)CNS(=O)(=O)CC1=CC=CC=C1 AOUQQCVNASPOLA-UHFFFAOYSA-M 0.000 description 1
- ZXHPIRBCWZNECL-UHFFFAOYSA-M sodium (thiophen-2-ylsulfonylamino)methyl-(2,4,6-trifluorophenoxy)phosphinate Chemical compound [Na+].[O-]P(=O)(CNS(=O)(=O)c1cccs1)Oc1c(F)cc(F)cc1F ZXHPIRBCWZNECL-UHFFFAOYSA-M 0.000 description 1
- GIYAHZLRPHBAFC-UHFFFAOYSA-M sodium [(2,4-dinitrophenyl)sulfonylamino]methyl-(4-nitrophenoxy)phosphinate Chemical compound [Na+].[N+](=O)([O-])C1=CC=C(C=C1)OP([O-])(=O)CNS(=O)(=O)C1=C(C=C(C=C1)[N+](=O)[O-])[N+](=O)[O-] GIYAHZLRPHBAFC-UHFFFAOYSA-M 0.000 description 1
- MPAULPPUXOVXFI-UHFFFAOYSA-M sodium [(2-bromophenyl)sulfonylamino]methyl-(4-nitrophenoxy)phosphinate Chemical compound [Na+].[N+](=O)([O-])C1=CC=C(C=C1)OP([O-])(=O)CNS(=O)(=O)C1=C(C=CC=C1)Br MPAULPPUXOVXFI-UHFFFAOYSA-M 0.000 description 1
- UNQHVSIERJLUSW-UHFFFAOYSA-M sodium [(3,4-dichlorophenyl)sulfonylamino]methyl-(4-nitrophenoxy)phosphinate Chemical compound [Na+].[N+](=O)([O-])C1=CC=C(C=C1)OP([O-])(=O)CNS(=O)(=O)C1=CC(=C(C=C1)Cl)Cl UNQHVSIERJLUSW-UHFFFAOYSA-M 0.000 description 1
- WOIDIXHSJUHWNH-UHFFFAOYSA-M sodium [(4-chloro-3-nitrophenyl)sulfonylamino]methyl-(4-nitrophenoxy)phosphinate Chemical compound [Na+].[O-][N+](=O)c1ccc(OP([O-])(=O)CNS(=O)(=O)c2ccc(Cl)c(c2)[N+]([O-])=O)cc1 WOIDIXHSJUHWNH-UHFFFAOYSA-M 0.000 description 1
- VZCBDHPRZXAECH-UHFFFAOYSA-M sodium [(4-chlorophenyl)sulfonylamino]methyl-(4-nitrophenoxy)phosphinate Chemical compound [Na+].[O-][N+](=O)c1ccc(OP([O-])(=O)CNS(=O)(=O)c2ccc(Cl)cc2)cc1 VZCBDHPRZXAECH-UHFFFAOYSA-M 0.000 description 1
- LPXPICVHXVWKDS-UHFFFAOYSA-M sodium [(4-fluorophenyl)sulfonylamino]methyl-(4-nitrophenoxy)phosphinate Chemical compound [Na+].[O-][N+](=O)c1ccc(OP([O-])(=O)CNS(=O)(=O)c2ccc(F)cc2)cc1 LPXPICVHXVWKDS-UHFFFAOYSA-M 0.000 description 1
- FFQLKNINBZPYRB-UHFFFAOYSA-M sodium [(4-methoxyphenyl)sulfonylamino]methyl-(4-nitrophenoxy)phosphinate Chemical compound [Na+].COc1ccc(cc1)S(=O)(=O)NCP([O-])(=O)Oc1ccc(cc1)[N+]([O-])=O FFQLKNINBZPYRB-UHFFFAOYSA-M 0.000 description 1
- NOTJPZUZYWGBIN-UHFFFAOYSA-M sodium [(4-tert-butylphenyl)sulfonylamino]methyl-(4-nitrophenoxy)phosphinate Chemical compound [Na+].[N+](=O)([O-])C1=CC=C(C=C1)OP([O-])(=O)CNS(=O)(=O)C1=CC=C(C=C1)C(C)(C)C NOTJPZUZYWGBIN-UHFFFAOYSA-M 0.000 description 1
- DYWPRKCACJAKJE-UHFFFAOYSA-M sodium [(5-bromothiophen-2-yl)sulfonylamino]methyl-(2-chloropyridin-3-yl)oxyphosphinate Chemical compound [Na+].[O-]P(=O)(CNS(=O)(=O)c1ccc(Br)s1)Oc1cccnc1Cl DYWPRKCACJAKJE-UHFFFAOYSA-M 0.000 description 1
- QIGSZDUOPMQRRX-UHFFFAOYSA-M sodium [(5-bromothiophen-2-yl)sulfonylamino]methyl-(4-nitrophenoxy)phosphinate Chemical compound [Na+].[N+](=O)([O-])C1=CC=C(C=C1)OP([O-])(=O)CNS(=O)(=O)C=1SC(=CC=1)Br QIGSZDUOPMQRRX-UHFFFAOYSA-M 0.000 description 1
- QMPVMCBWKBYVNM-UHFFFAOYSA-M sodium [(5-bromothiophen-2-yl)sulfonylamino]methyl-(5-chloropyridin-3-yl)oxyphosphinate Chemical compound [Na+].[O-]P(=O)(CNS(=O)(=O)c1ccc(Br)s1)Oc1cncc(Cl)c1 QMPVMCBWKBYVNM-UHFFFAOYSA-M 0.000 description 1
- DHXNMGRVYPLQCU-UHFFFAOYSA-M sodium benzenesulfonamidomethyl-(4-nitrophenoxy)phosphinate Chemical compound [Na+].[N+](=O)([O-])C1=CC=C(C=C1)OP([O-])(=O)CNS(=O)(=O)C1=CC=CC=C1 DHXNMGRVYPLQCU-UHFFFAOYSA-M 0.000 description 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
- 235000017557 sodium bicarbonate Nutrition 0.000 description 1
- 229910000029 sodium carbonate Inorganic materials 0.000 description 1
- 235000017550 sodium carbonate Nutrition 0.000 description 1
- JIVCKEZDCNJMHF-UHFFFAOYSA-M sodium methoxy-[(thiophen-2-ylsulfonylamino)methyl]phosphinate Chemical compound [Na+].COP([O-])(=O)CNS(=O)(=O)C=1SC=CC=1 JIVCKEZDCNJMHF-UHFFFAOYSA-M 0.000 description 1
- YPPQYORGOMWNMX-UHFFFAOYSA-L sodium phosphonate pentahydrate Chemical compound [Na+].[Na+].[O-]P([O-])=O YPPQYORGOMWNMX-UHFFFAOYSA-L 0.000 description 1
- BZCHNRQTZIWZCM-UHFFFAOYSA-M sodium pyridin-3-yloxy-[(pyridin-3-ylsulfonylamino)methyl]phosphinate Chemical compound [Na+].[O-]P(=O)(CNS(=O)(=O)c1cccnc1)Oc1cccnc1 BZCHNRQTZIWZCM-UHFFFAOYSA-M 0.000 description 1
- LLOZYWIZOBOHGX-UHFFFAOYSA-M sodium pyridin-3-yloxy-[(thiophen-3-ylsulfonylamino)methyl]phosphinate Chemical compound [Na+].[O-]P(=O)(CNS(=O)(=O)c1ccsc1)Oc1cccnc1 LLOZYWIZOBOHGX-UHFFFAOYSA-M 0.000 description 1
- 159000000000 sodium salts Chemical class 0.000 description 1
- YCSXWLOMJJYNCE-UHFFFAOYSA-M sodium;(2-bromopyridin-3-yl)oxy-[[(4-fluorophenyl)sulfonylamino]methyl]phosphinate Chemical compound [Na+].C=1C=CN=C(Br)C=1OP(=O)([O-])CNS(=O)(=O)C1=CC=C(F)C=C1 YCSXWLOMJJYNCE-UHFFFAOYSA-M 0.000 description 1
- NGKHVTUYSWPCIG-UHFFFAOYSA-M sodium;(2-chloropyridin-3-yl)oxy-[(thiophen-2-ylsulfonylamino)methyl]phosphinate Chemical compound [Na+].C=1C=CN=C(Cl)C=1OP(=O)([O-])CNS(=O)(=O)C1=CC=CS1 NGKHVTUYSWPCIG-UHFFFAOYSA-M 0.000 description 1
- PURQRETTWIPIAF-UHFFFAOYSA-M sodium;(naphthalen-2-ylsulfonylamino)methyl-(4-nitrophenoxy)phosphinate Chemical compound [Na+].C1=CC([N+](=O)[O-])=CC=C1OP([O-])(=O)CNS(=O)(=O)C1=CC=C(C=CC=C2)C2=C1 PURQRETTWIPIAF-UHFFFAOYSA-M 0.000 description 1
- 229960000268 spectinomycin Drugs 0.000 description 1
- UNFWWIHTNXNPBV-WXKVUWSESA-N spectinomycin Chemical compound O([C@@H]1[C@@H](NC)[C@@H](O)[C@H]([C@@H]([C@H]1O1)O)NC)[C@]2(O)[C@H]1O[C@H](C)CC2=O UNFWWIHTNXNPBV-WXKVUWSESA-N 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 238000005556 structure-activity relationship Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 125000003107 substituted aryl group Chemical group 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- FKENQMMABCRJMK-RITPCOANSA-N sulbactam Chemical compound O=S1(=O)C(C)(C)[C@H](C(O)=O)N2C(=O)C[C@H]21 FKENQMMABCRJMK-RITPCOANSA-N 0.000 description 1
- 229960005256 sulbactam Drugs 0.000 description 1
- 229960005404 sulfamethoxazole Drugs 0.000 description 1
- 125000000565 sulfonamide group Chemical group 0.000 description 1
- 239000011593 sulfur Substances 0.000 description 1
- FWMUJAIKEJWSSY-UHFFFAOYSA-N sulfur dichloride Chemical compound ClSCl FWMUJAIKEJWSSY-UHFFFAOYSA-N 0.000 description 1
- JLKIGFTWXXRPMT-UHFFFAOYSA-N sulphamethoxazole Chemical compound O1C(C)=CC(NS(=O)(=O)C=2C=CC(N)=CC=2)=N1 JLKIGFTWXXRPMT-UHFFFAOYSA-N 0.000 description 1
- 239000012622 synthetic inhibitor Substances 0.000 description 1
- 230000009885 systemic effect Effects 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 235000019364 tetracycline Nutrition 0.000 description 1
- 229940040944 tetracyclines Drugs 0.000 description 1
- 150000003522 tetracyclines Chemical class 0.000 description 1
- 125000003718 tetrahydrofuranyl group Chemical group 0.000 description 1
- 125000003831 tetrazolyl group Chemical group 0.000 description 1
- 125000001984 thiazolidinyl group Chemical group 0.000 description 1
- LLNHCWKGMQIKPY-UHFFFAOYSA-N thionitrosomethylphosphonic acid Chemical compound S=NCP(O)(O)=O LLNHCWKGMQIKPY-UHFFFAOYSA-N 0.000 description 1
- YSPWSQNKRBSICH-UHFFFAOYSA-N thiophene-3-sulfonyl chloride Chemical compound ClS(=O)(=O)C=1C=CSC=1 YSPWSQNKRBSICH-UHFFFAOYSA-N 0.000 description 1
- 229940027257 timentin Drugs 0.000 description 1
- 125000003944 tolyl group Chemical group 0.000 description 1
- BDZBKCUKTQZUTL-UHFFFAOYSA-N triethyl phosphite Chemical compound CCOP(OCC)OCC BDZBKCUKTQZUTL-UHFFFAOYSA-N 0.000 description 1
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 description 1
- 125000004360 trifluorophenyl group Chemical group 0.000 description 1
- IEDVJHCEMCRBQM-UHFFFAOYSA-N trimethoprim Chemical compound COC1=C(OC)C(OC)=CC(CC=2C(=NC(N)=NC=2)N)=C1 IEDVJHCEMCRBQM-UHFFFAOYSA-N 0.000 description 1
- 229960001082 trimethoprim Drugs 0.000 description 1
- XSQUKJJJFZCRTK-UHFFFAOYSA-N urea group Chemical group NC(=O)N XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 1
- 229960003165 vancomycin Drugs 0.000 description 1
- MYPYJXKWCTUITO-UHFFFAOYSA-N vancomycin Natural products O1C(C(=C2)Cl)=CC=C2C(O)C(C(NC(C2=CC(O)=CC(O)=C2C=2C(O)=CC=C3C=2)C(O)=O)=O)NC(=O)C3NC(=O)C2NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(CC(C)C)NC)C(O)C(C=C3Cl)=CC=C3OC3=CC2=CC1=C3OC1OC(CO)C(O)C(O)C1OC1CC(C)(N)C(O)C(C)O1 MYPYJXKWCTUITO-UHFFFAOYSA-N 0.000 description 1
- MYPYJXKWCTUITO-LYRMYLQWSA-O vancomycin(1+) Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=C2C=C3C=C1OC1=CC=C(C=C1Cl)[C@@H](O)[C@H](C(N[C@@H](CC(N)=O)C(=O)N[C@H]3C(=O)N[C@H]1C(=O)N[C@H](C(N[C@@H](C3=CC(O)=CC(O)=C3C=3C(O)=CC=C1C=3)C([O-])=O)=O)[C@H](O)C1=CC=C(C(=C1)Cl)O2)=O)NC(=O)[C@@H](CC(C)C)[NH2+]C)[C@H]1C[C@](C)([NH3+])[C@H](O)[C@H](C)O1 MYPYJXKWCTUITO-LYRMYLQWSA-O 0.000 description 1
- 230000035899 viability Effects 0.000 description 1
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 1
- 229920002554 vinyl polymer Polymers 0.000 description 1
- 239000003039 volatile agent Substances 0.000 description 1
- 150000003738 xylenes Chemical class 0.000 description 1
- 125000005023 xylyl group Chemical group 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6553—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having sulfur atoms, with or without selenium or tellurium atoms, as the only ring hetero atoms
- C07F9/655345—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having sulfur atoms, with or without selenium or tellurium atoms, as the only ring hetero atoms the sulfur atom being part of a five-membered ring
- C07F9/655354—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having sulfur atoms, with or without selenium or tellurium atoms, as the only ring hetero atoms the sulfur atom being part of a five-membered ring condensed with carbocyclic rings or carbocyclic ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/28—Phosphorus compounds with one or more P—C bonds
- C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
- C07F9/40—Esters thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/06—Phosphorus compounds without P—C bonds
- C07F9/22—Amides of acids of phosphorus
- C07F9/24—Esteramides
- C07F9/2454—Esteramides the amide moiety containing a substituent or a structure which is considered as characteristic
- C07F9/2479—Compounds containing the structure P(=X)n-N-acyl, P(=X)n-N-heteroatom, P(=X)n-N-CN (X = O, S, Se; n = 0, 1)
- C07F9/2491—Compounds containing the structure P(=X)n-N-acyl, P(=X)n-N-heteroatom, P(=X)n-N-CN (X = O, S, Se; n = 0, 1) containing the structure P(=X)n-N-N (X = O, S, Se; n = 0, 1)
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/28—Phosphorus compounds with one or more P—C bonds
- C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
- C07F9/3804—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)] not used, see subgroups
- C07F9/3808—Acyclic saturated acids which can have further substituents on alkyl
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/28—Phosphorus compounds with one or more P—C bonds
- C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
- C07F9/40—Esters thereof
- C07F9/4003—Esters thereof the acid moiety containing a substituent or a structure which is considered as characteristic
- C07F9/4006—Esters of acyclic acids which can have further substituents on alkyl
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/28—Phosphorus compounds with one or more P—C bonds
- C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
- C07F9/42—Halides thereof
- C07F9/425—Acid or estermonohalides thereof, e.g. RP(=X)(YR)(Hal) (X, Y = O, S; R = H, or hydrocarbon group)
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/28—Phosphorus compounds with one or more P—C bonds
- C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
- C07F9/44—Amides thereof
- C07F9/4403—Amides thereof the acid moiety containing a substituent or a structure which is considered as characteristic
- C07F9/4407—Amides of acyclic saturated acids which can have further substituents on alkyl
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/553—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
- C07F9/572—Five-membered rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/553—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
- C07F9/572—Five-membered rings
- C07F9/5728—Five-membered rings condensed with carbocyclic rings or carbocyclic ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/553—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
- C07F9/576—Six-membered rings
- C07F9/58—Pyridine rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/553—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
- C07F9/576—Six-membered rings
- C07F9/60—Quinoline or hydrogenated quinoline ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6536—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having nitrogen and sulfur atoms with or without oxygen atoms, as the only ring hetero atoms
- C07F9/6539—Five-membered rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6536—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having nitrogen and sulfur atoms with or without oxygen atoms, as the only ring hetero atoms
- C07F9/6539—Five-membered rings
- C07F9/65392—Five-membered rings containing two nitrogen atoms
- C07F9/65395—Five-membered rings containing two nitrogen atoms having the two nitrogen atoms in positions 1 and 2
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6536—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having nitrogen and sulfur atoms with or without oxygen atoms, as the only ring hetero atoms
- C07F9/6539—Five-membered rings
- C07F9/6541—Five-membered rings condensed with carbocyclic rings or carbocyclic ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/655—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms
- C07F9/65515—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms the oxygen atom being part of a five-membered ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/655—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms
- C07F9/65515—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms the oxygen atom being part of a five-membered ring
- C07F9/65517—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms the oxygen atom being part of a five-membered ring condensed with carbocyclic rings or carbocyclic ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6553—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having sulfur atoms, with or without selenium or tellurium atoms, as the only ring hetero atoms
- C07F9/655345—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having sulfur atoms, with or without selenium or tellurium atoms, as the only ring hetero atoms the sulfur atom being part of a five-membered ring
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Crystallography & Structural Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Cosmetics (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US14236299P | 1999-07-06 | 1999-07-06 | |
| US142362P | 1999-07-06 | ||
| PCT/US2000/018344 WO2001002411A1 (en) | 1999-07-06 | 2000-07-05 | SULFONAMIDOMETHYL PHOSPHONATE INHIBITORS OF β-LACTAMASE |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| DE60024455D1 DE60024455D1 (en) | 2006-01-05 |
| DE60024455T2 true DE60024455T2 (de) | 2006-08-03 |
Family
ID=22499561
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE60024455T Expired - Lifetime DE60024455T2 (de) | 1999-07-06 | 2000-07-05 | Sulfonamidomethylphosphonat-BETA-LACTAMASE-Inhibitoren |
Country Status (11)
| Country | Link |
|---|---|
| US (2) | US6472406B1 (https=) |
| EP (1) | EP1194436B1 (https=) |
| JP (1) | JP4226818B2 (https=) |
| KR (1) | KR100686988B1 (https=) |
| AT (1) | ATE311397T1 (https=) |
| AU (1) | AU770599B2 (https=) |
| CA (1) | CA2377762C (https=) |
| DE (1) | DE60024455T2 (https=) |
| ES (1) | ES2250150T3 (https=) |
| MX (1) | MXPA02000246A (https=) |
| WO (1) | WO2001002411A1 (https=) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6884791B2 (en) * | 1999-07-06 | 2005-04-26 | Methylgene, Inc. | Inhibitors of β-lactamase |
| US6921756B2 (en) * | 1999-07-06 | 2005-07-26 | Methylgene, Inc. | Inhibitors of β-lactamase |
| ES2258980T3 (es) * | 1999-08-16 | 2006-09-16 | Revaax Pharmaceuticals Llc | Composiciones farmaceuticas que comprenden acido clavulanico o derivados del mismo para el tratamiento de trastornos del comportamiento. |
| US6426342B2 (en) * | 1999-08-16 | 2002-07-30 | Revaax Pharmaceuticals, Llc | Use of β-lactamase inhibitors as neuroprotectants |
| US20100317625A1 (en) * | 2006-05-22 | 2010-12-16 | Dininno Frank | Novel sulfonamidomethylphosphonate inhibitors of beta-lactamase |
| ES2543842T3 (es) * | 2006-05-22 | 2015-08-24 | Methylgene Inc. | Nuevos inhibidores de la beta-lactamasa |
| EP2069347A2 (en) * | 2006-09-27 | 2009-06-17 | Merck & Co., Inc. | Novel inhibitors of beta-lactamase |
| WO2009091856A2 (en) | 2008-01-18 | 2009-07-23 | Merck & Co., Inc. | Beta-lactamase inhibitors |
| US20110046101A1 (en) * | 2008-03-17 | 2011-02-24 | Dmitrienko Gary I | Bate-lactamase inhibitors |
| BRPI1013901A2 (pt) * | 2009-04-29 | 2019-09-24 | Rexahn Pharmaceuticals Inc | formulação de clavulanato para neuroproteção e tratamento de distúrbios neurodegenerativos |
| WO2015112441A1 (en) | 2014-01-22 | 2015-07-30 | Merck Sharp & Dohme Corp. | Metallo-beta-lactamase inhibitors |
| EP3139918B1 (en) | 2014-05-09 | 2019-12-25 | Merck Sharp & Dohme Corp. | Beta-tetrazolyl-propionic acids as metallo-beta-lactamase inhibitors |
| WO2016206101A1 (en) | 2015-06-26 | 2016-12-29 | Merck Sharp & Dohme Corp. | Metallo-beta-lactamase inhibitors |
| BR112018008597B1 (pt) | 2015-10-28 | 2022-03-03 | Fmc Corporation | Composto, composições herbicidas, mistura herbicida e método para o controle do crescimento de vegetação indesejada |
| WO2019018186A1 (en) | 2017-07-17 | 2019-01-24 | Merck Sharp & Dohme Corp. | Metallo-beta-lactamase inhibitors and methods of use thereof |
| CN121005742A (zh) * | 2024-05-23 | 2025-11-25 | 华东师范大学 | 作为cd73抑制剂衍生物及其应用 |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2059923C3 (de) | 1970-12-05 | 1979-01-25 | Knoll Ag, 6700 Ludwigshafen | l-a-Isopropyl-o-[(N-methyl-N-homoveratryl)v-aminopropyl] -3,4-dimethoxyphenylacetonitril, Verfahren zu dessen Herstellung und dieses enthaltende Arzneimittel |
| US3959551A (en) | 1972-03-30 | 1976-05-25 | Hooker Chemicals & Plastics Corporation | Dialkyl alkyl and aromatic sulfonamidomethyl phosphonates |
| US3870771A (en) | 1972-03-30 | 1975-03-11 | Hooker Chemicals Plastics Corp | Dialkyl alkyl and aromatic sulfonamidomethyl phosphonates |
| DE2261081A1 (de) | 1972-12-14 | 1974-06-27 | Bayer Ag | Amidomethanphosphonsaeure-derivate |
| US4031170A (en) | 1973-08-06 | 1977-06-21 | Monsanto Company | Phosphorus compounds |
| US4032601A (en) | 1973-08-06 | 1977-06-28 | Monsanto Company | Process for the production of sulfonamide phosphonates |
| JPS5490160A (en) | 1977-12-26 | 1979-07-17 | Ihara Chem Ind Co Ltd | Alpha,alpha-disubstituted-benzylcyanide derivatives |
| JPS62126160A (ja) | 1985-11-25 | 1987-06-08 | Hokuriku Seiyaku Co Ltd | 新規なフエニルブチラルデヒド誘導体およびその製造法 |
| DE3628300A1 (de) | 1986-08-21 | 1988-02-25 | Schering Ag | Alkan- und alkoxyalkan-derivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende insektizide und akarizide mittel |
| EP0505122A1 (en) | 1991-03-21 | 1992-09-23 | Zeneca Limited | Alpha, alpha-dialkylbenzyl derivatives |
| GB9410721D0 (en) | 1994-05-27 | 1994-07-13 | Chiroscience Ltd | Chiral compounds and their resolution |
| US5681821A (en) | 1994-10-18 | 1997-10-28 | Georgia Tech Research Corp. | Fluorescent 1-peptidylaminoalkanephosphonate derivatives |
| GB9602516D0 (en) | 1996-02-08 | 1996-04-10 | Chiroscience Ltd | Racemisation |
| CA2204082A1 (en) | 1996-05-03 | 1997-11-03 | Michael William John Urquhart | Pharmaceutical compounds |
| WO1998056392A1 (en) * | 1997-06-13 | 1998-12-17 | Northwestern University | INHIBITORS OF β-LACTAMASES AND USES THEREFOR |
| KR100591572B1 (ko) | 1997-12-24 | 2006-06-20 | 메틸진, 인크. | 신규의 β-락타마아제 및 DD-펩티다아제 저해제 |
| ATE227295T1 (de) | 1998-07-16 | 2002-11-15 | Aventis Pharma Gmbh | Phosphin- und phosphonsäurederivate als arzneimittel |
-
2000
- 2000-07-05 KR KR1020027000135A patent/KR100686988B1/ko not_active Expired - Fee Related
- 2000-07-05 ES ES00943381T patent/ES2250150T3/es not_active Expired - Lifetime
- 2000-07-05 DE DE60024455T patent/DE60024455T2/de not_active Expired - Lifetime
- 2000-07-05 EP EP00943381A patent/EP1194436B1/en not_active Expired - Lifetime
- 2000-07-05 WO PCT/US2000/018344 patent/WO2001002411A1/en not_active Ceased
- 2000-07-05 MX MXPA02000246A patent/MXPA02000246A/es active IP Right Grant
- 2000-07-05 AU AU57858/00A patent/AU770599B2/en not_active Ceased
- 2000-07-05 CA CA002377762A patent/CA2377762C/en not_active Expired - Fee Related
- 2000-07-05 US US09/610,456 patent/US6472406B1/en not_active Expired - Fee Related
- 2000-07-05 JP JP2001507847A patent/JP4226818B2/ja not_active Expired - Fee Related
- 2000-07-05 AT AT00943381T patent/ATE311397T1/de not_active IP Right Cessation
-
2002
- 2002-10-08 US US10/266,213 patent/US7030103B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| AU5785800A (en) | 2001-01-22 |
| DE60024455D1 (en) | 2006-01-05 |
| ATE311397T1 (de) | 2005-12-15 |
| CA2377762C (en) | 2008-09-30 |
| KR20020022084A (ko) | 2002-03-23 |
| JP4226818B2 (ja) | 2009-02-18 |
| AU770599B2 (en) | 2004-02-26 |
| US6472406B1 (en) | 2002-10-29 |
| MXPA02000246A (es) | 2003-08-20 |
| EP1194436B1 (en) | 2005-11-30 |
| WO2001002411A1 (en) | 2001-01-11 |
| ES2250150T3 (es) | 2006-04-16 |
| US20040059115A1 (en) | 2004-03-25 |
| EP1194436A1 (en) | 2002-04-10 |
| JP2003503505A (ja) | 2003-01-28 |
| KR100686988B1 (ko) | 2007-02-27 |
| CA2377762A1 (en) | 2001-01-11 |
| US7030103B2 (en) | 2006-04-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE60024455T2 (de) | Sulfonamidomethylphosphonat-BETA-LACTAMASE-Inhibitoren | |
| US5436265A (en) | 1-aroyl-3-indolyl alkanoic acids and derivatives thereof useful as anti-inflammatory agents | |
| DE2733658C2 (https=) | ||
| EP0042026A1 (de) | 3,4-Disubstituierte Azetidin-2-onverbindungen und Verfahren zu ihrer Herstellung | |
| US5273990A (en) | Phosphono substituted tetrazole derivatives | |
| CH630073A5 (de) | Verfahren zur herstellung von 2-azetidinonverbindungen. | |
| US7514556B2 (en) | Inhibitors of β-lactamase | |
| US6921756B2 (en) | Inhibitors of β-lactamase | |
| AU755799B2 (en) | Novel beta-lactamase and DD-peptidase inhibitors | |
| US4046774A (en) | Process for N-phosphorylation of heterocyclic amines | |
| US6599889B2 (en) | Acyl phosphonate inhibitors of β-lactamases | |
| EP0433928B1 (de) | 2-Formylbenzylphosphonsäure-Derivate, deren Herstellung und ihre Verwendung zur Behandlung von durch Viren verursachte Krankheiten | |
| US5278152A (en) | 2-formylbenzylphosphonic acid derivatives useful for the treatment of diseases caused by viruses | |
| EP0313997A2 (de) | Arzneimittel, darin enthaltene phosphorhaltige 2-Isoxazoline und Isoxazole, sowie Herstellungsverfahren für diese heterocyclischen Verbindungen | |
| CH660736A5 (de) | Carbapenemderivate. | |
| EP0059683A2 (de) | 7-Acylamido-3-cephem-4-carbonsäureverbindungen, Verfahren zu ihrer Herstellung, pharmazeutische Präparate, welche diese Verbindungen enthalten, und Verwendung von letzteren | |
| DE2714628A1 (de) | Substituierte phenylessigsaeureverbindungen und verfahren zu ihrer herstellung | |
| DE2365705A1 (de) | Pharmazeutisch wertvolle neue 1,2,4-oxadiazolyl-essigsaeure-derivate und verfahren zu ihrer herstellung und ihre verwendung | |
| CA2325523A1 (en) | Prodrugs of phosphorous-containing pharmaceuticals | |
| CH566340A5 (en) | 3-unsubstd ceph-3 (or 2)-em-4-carboxylic acids - with antibiotic activity |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 8364 | No opposition during term of opposition |